drMIPS

In this example below you will see how to do a drMIPS with some HTML / CSS and Javascript

Thumbnail
This awesome code was written by Coolok, you can see more from this user in the personal repository.
You can find the original code on Codepen.io
Copyright Coolok ©

Technologies

  • HTML
  • JavaScript
<!DOCTYPE html>
<html lang="en" >

<head>
  <meta charset="UTF-8">
  <title>drMIPS</title>
  <meta name="viewport" content="width=device-width, initial-scale=1">
  
  
  
  
</head>

<body>

  <div>
  drMIPS
</div>
<input id="spec" placeholder="specialization" />
<div id="result"></div>
  <script src='https://cdnjs.cloudflare.com/ajax/libs/jquery/3.1.1/jquery.min.js'></script>

  

    <script  src="js/index.js"></script>




</body>

</html>

/*Downloaded from https://www.codeseek.co/Coolok/drmips-WjVaEL */
var specializations = [
    {
        id: 1,
        specialization: "Internal Medicine"
    },
    {
        id: 2,
        specialization: "General Practice/Family Medicine"
    },
    {
        id: 3,
        specialization: "Cardiology"
    },
    {
        id: 4,
        specialization: "Ophthalmology"
    },
    {
        id: 5,
        specialization: "Preventive Medicine"
    },
    {
        id: 6,
        specialization: "Allergy/Immunology"
    },
    {
        id: 7,
        specialization: "Gastroenterology"
    },
    {
        id: 8,
        specialization: "Hospitalists"
    },
    {
        id: 9,
        specialization: "Obstetrics/Gynecolog"
    },
    {
        id: 10,
        specialization: "Mental/Behavioral Health"
    },
    {
        id: 11,
        specialization: "Dermatology"
    },
    {
        id: 12,
        specialization: "General Surgery"
    },
    {
        id: 13,
        specialization: " Anesthesiology"
    },
    {
        id: 14,
        specialization: "Emergency Medicine"
    },
    {
        id: 15,
        specialization: "Neurology"
    },
    {
        id: 16,
        specialization: "Pediatrics"
    },
    {
        id: 17,
        specialization: "Otolaryngology"
    },
    {
        id: 18,
        specialization: "Diagnostic Radiology"
    },
    {
        id: 19,
        specialization: "Pathology"
    },
    {
        id: 20,
        specialization: "Rheumatology"
    },
    {
        id: 21,
        specialization: "Orthopedic Surgery"
    },
    {
        id: 22,
        specialization: "Thoracic Surgery"
    },
    {
        id: 23,
        specialization: "Urology"
    },
    {
        id: 24,
        specialization: "Vascular Surgery"
    },
    {
        id: 25,
        specialization: "Preventive Medicine"
    },
    {
        id: 26,
        specialization: "Plastic Surgery"
    },
    {
        id: 27,
        specialization: "Emergency Medicine"
    },
    {
        id: 28,
        specialization: "Radiation Oncology"
    },
    {
        id: 29,
        specialization: "Electrophysiology Cardiac Specialist"
    }
];
var qMes = [
    {
        Measure_Name: "Acute Otitis Externa (AOE): Topical Therapy",
        Measure_ID: 91,
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "60.47 - 69.56",
        Decile_4: "69.57 - 78.25",
        Decile_5: "78.26 - 83.01",
        Decile_6: "83.02 - 87.97",
        Decile_7: "87.98 - 93.32",
        Decile_8: "93.33 - 99.99",
        Decile_9: "--",
        Decile_10: 100
    },
    {
        Measure_Name: "Adenoma detection rate",
        Measure_ID: "GIQIC 1",
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Outcome",
        Benchmark: "Y",
        Decile_3: "28.99 - 32.18",
        Decile_4: "32.19 - 35.75",
        Decile_5: "35.76 - 38.80",
        Decile_6: "38.81 - 41.92",
        Decile_7: "41.93 - 45.74",
        Decile_8: "45.75 - 49.29",
        Decile_9: "49.30 - 54.69",
        Decile_10: ">= 54.70"
    },
    {
        Measure_Name: "Adequate Compression at each visit for Patients with Venous Leg Ulcers (VLU)",
        Measure_ID: "CDR 5",
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "75.20 - 90.31",
        Decile_4: "90.32 - 93.58",
        Decile_5: "93.59 - 94.63",
        Decile_6: "94.64 - 95.82",
        Decile_7: "95.83 - 97.23",
        Decile_8: "97.24 - 99.09",
        Decile_9: "99.10 - 99.99",
        Decile_10: 100
    },
    {
        Measure_Name: "Adequate Off-loading of Diabetic Foot Ulcers at each visit",
        Measure_ID: "CDR 1",
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "40.13 - 58.05",
        Decile_4: "58.06 - 72.34",
        Decile_5: "72.35 - 83.92",
        Decile_6: "83.93 - 91.29",
        Decile_7: "91.30 - 95.29",
        Decile_8: "95.30 - 97.41",
        Decile_9: "97.42 - 98.87",
        Decile_10: ">= 98.88"
    },
    {
        Measure_Name: "Adherence to Antipsychotic Medications for Individuals with Schizophrenia",
        Measure_ID: 383,
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Outcome",
        Benchmark: "Y",
        Decile_3: "34.78 - 60.50",
        Decile_4: "60.51 - 72.36",
        Decile_5: "72.37 - 80.54",
        Decile_6: "80.55 - 91.99",
        Decile_7: "92.00 - 99.99",
        Decile_8: "--",
        Decile_9: "--",
        Decile_10: 100
    },
    {
        Measure_Name: "Adult Kidney Disease: Blood Pressure Management",
        Measure_ID: 122,
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Outcome",
        Benchmark: "Y",
        Decile_3: "60.62 - 67.49",
        Decile_4: "67.50 - 75.46",
        Decile_5: "75.47 - 87.87",
        Decile_6: "87.88 - 94.33",
        Decile_7: "94.34 - 96.35",
        Decile_8: "96.36 - 97.77",
        Decile_9: "97.78 - 99.74",
        Decile_10: ">= 99.75"
    },
    {
        Measure_Name: "Adult Kidney Disease: Laboratory Testing (Lipid Profile)",
        Measure_ID: 121,
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "20.00 - 34.26",
        Decile_4: "34.27 - 45.70",
        Decile_5: "45.71 - 58.96",
        Decile_6: "58.97 - 69.48",
        Decile_7: "69.49 - 78.60",
        Decile_8: "78.61 - 90.15",
        Decile_9: "90.16 - 99.99",
        Decile_10: 100
    },
    {
        Measure_Name: "Adult Major Depressive Disorder (MDD): Suicide Risk Assessment",
        Measure_ID: 107,
        Submission_Method: "EHR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "53.85 - 64.74",
        Decile_4: "64.75 - 70.90",
        Decile_5: "70.91 - 86.68",
        Decile_6: "86.69 - 89.31",
        Decile_7: "89.32 - 92.90",
        Decile_8: "92.91 - 96.54",
        Decile_9: "96.55 - 98.67",
        Decile_10: ">= 98.68"
    },
    {
        Measure_Name: "Adult Sinusitis: Antibiotic Prescribed for Acute Sinusitis (Appropriate Use)",
        Measure_ID: 331,
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "89.07 - 82.41",
        Decile_4: "82.40 - 71.44",
        Decile_5: "71.43 - 46.46",
        Decile_6: "46.45 - 16.91",
        Decile_7: "16.90 - 0.60",
        Decile_8: "0.59 - 0.01",
        Decile_9: "--",
        Decile_10: 0
    },
    {
        Measure_Name: "Adult Sinusitis: Appropriate Choice of Antibiotic",
        Measure_ID: "ACEP 17",
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "47.19 - 51.88",
        Decile_4: "51.89 - 57.13",
        Decile_5: "57.14 - 60.33",
        Decile_6: "60.34 - 62.36",
        Decile_7: "62.37 - 65.25",
        Decile_8: "65.26 - 67.30",
        Decile_9: "67.31 - 73.63",
        Decile_10: ">= 73.64"
    },
    {
        Measure_Name: "Adult Sinusitis: Appropriate Choice of Antibiotic: Amoxicillin Prescribed for Patients with Acute Bacterial Sinusitis",
        Measure_ID: 332,
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "44.39 - 47.99",
        Decile_4: "48.00 - 51.88",
        Decile_5: "51.89 - 57.57",
        Decile_6: "57.58 - 64.99",
        Decile_7: "65.00 - 72.72",
        Decile_8: "72.73 - 95.99",
        Decile_9: "96.00 - 99.99",
        Decile_10: 100
    },
    {
        Measure_Name: "Advance Care Plan",
        Measure_ID: 47,
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "16.52 - 38.11",
        Decile_4: "38.12 - 59.14",
        Decile_5: "59.15 - 74.99",
        Decile_6: "75.00 - 88.71",
        Decile_7: "88.72 - 96.29",
        Decile_8: "96.30 - 99.17",
        Decile_9: "99.18 - 99.99",
        Decile_10: 100
    },
    {
        Measure_Name: "Age-Related Macular Degeneration (AMD): Counseling on Antioxidant Supplement",
        Measure_ID: 140,
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "32.26 - 48.38",
        Decile_4: "48.39 - 65.54",
        Decile_5: "65.55 - 78.94",
        Decile_6: "78.95 - 89.99",
        Decile_7: "90.00 - 97.43",
        Decile_8: "97.44 - 99.99",
        Decile_9: "--",
        Decile_10: 100
    },
    {
        Measure_Name: "Age-Related Macular Degeneration (AMD): Dilated Macular Examination",
        Measure_ID: 14,
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "31.01 - 55.12",
        Decile_4: "55.13 - 77.24",
        Decile_5: "77.25 - 91.17",
        Decile_6: "91.18 - 98.18",
        Decile_7: "98.19 - 99.99",
        Decile_8: "--",
        Decile_9: "--",
        Decile_10: 100
    },
    {
        Measure_Name: "Alcohol Misuse Screening",
        Measure_ID: "PPRNET 22",
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "7.20 - 11.49",
        Decile_4: "11.50 - 34.51",
        Decile_5: "34.52 - 39.05",
        Decile_6: "39.06 - 46.85",
        Decile_7: "46.86 - 58.15",
        Decile_8: "58.16 - 77.21",
        Decile_9: "77.22 - 91.44",
        Decile_10: ">= 91.45"
    },
    {
        Measure_Name: "Anti-depressant Medication Management",
        Measure_ID: 9,
        Submission_Method: "EHR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "0.97 - 1.27",
        Decile_4: "1.28 - 1.52",
        Decile_5: "1.53 - 1.84",
        Decile_6: "1.85 - 2.37",
        Decile_7: "2.38 - 3.99",
        Decile_8: "4.00 - 61.47",
        Decile_9: "61.48 - 80.62",
        Decile_10: ">= 80.63"
    },
    {
        Measure_Name: "Antiplatelet Medication for High Risk Patients",
        Measure_ID: "PPRNET 8",
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "18.87 - 21.56",
        Decile_4: "21.57 - 29.81",
        Decile_5: "29.82 - 32.63",
        Decile_6: "32.64 - 34.82",
        Decile_7: "34.83 - 54.35",
        Decile_8: "54.36 - 64.93",
        Decile_9: "64.94 - 75.20",
        Decile_10: ">= 75.21"
    },
    {
        Measure_Name: "Antithrombotic Medication for Patients with Atrial Fibrillation",
        Measure_ID: "PPRNET 9",
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "55.95 - 59.81",
        Decile_4: "59.82 - 68.74",
        Decile_5: "68.75 - 73.32",
        Decile_6: "73.33 - 74.99",
        Decile_7: "75.00 - 82.97",
        Decile_8: "82.98 - 85.70",
        Decile_9: "85.71 - 87.49",
        Decile_10: ">= 87.50"
    },
    {
        Measure_Name: "Appropriate follow-up interval for normal colonoscopy in average risk patients",
        Measure_ID: "GIQIC 6",
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "82.14 - 87.00",
        Decile_4: "87.01 - 89.65",
        Decile_5: "89.66 - 91.83",
        Decile_6: "91.84 - 93.74",
        Decile_7: "93.75 - 95.09",
        Decile_8: "95.10 - 96.59",
        Decile_9: "96.60 - 98.20",
        Decile_10: ">= 98.21"
    },
    {
        Measure_Name: "Appropriate follow-up interval of 3 years recommended based on pathology findings from screening colonoscopy in average-risk patients",
        Measure_ID: "GIQIC 15",
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "68.18 - 74.32",
        Decile_4: "74.33 - 77.87",
        Decile_5: "77.88 - 80.70",
        Decile_6: "80.71 - 85.23",
        Decile_7: "85.24 - 89.17",
        Decile_8: "89.18 - 91.34",
        Decile_9: "91.35 - 94.38",
        Decile_10: ">= 94.39"
    },
    {
        Measure_Name: "Appropriate indication for colonoscopy",
        Measure_ID: "GIQIC 12",
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "82.27 - 86.05",
        Decile_4: "86.06 - 89.06",
        Decile_5: "89.07 - 91.34",
        Decile_6: "91.35 - 93.27",
        Decile_7: "93.28 - 94.80",
        Decile_8: "94.81 - 96.59",
        Decile_9: "96.60 - 98.44",
        Decile_10: ">= 98.45"
    },
    {
        Measure_Name: "Appropriate Testing for Children with Pharyngitis",
        Measure_ID: 66,
        Submission_Method: "EHR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "38.12 - 52.32",
        Decile_4: "52.33 - 67.64",
        Decile_5: "67.65 - 74.56",
        Decile_6: "74.57 - 80.94",
        Decile_7: "80.95 - 85.70",
        Decile_8: "85.71 - 89.15",
        Decile_9: "89.16 - 94.20",
        Decile_10: ">= 94.21"
    },
    {
        Measure_Name: "Appropriate Treatment for Children with Upper Respiratory Infection (URI)",
        Measure_ID: 65,
        Submission_Method: "EHR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "70.45 - 79.99",
        Decile_4: "80.00 - 87.99",
        Decile_5: "88.00 - 93.05",
        Decile_6: "93.06 - 95.64",
        Decile_7: "95.65 - 97.29",
        Decile_8: "97.30 - 98.96",
        Decile_9: "98.97 - 99.99",
        Decile_10: 100
    },
    {
        Measure_Name: "Appropriate Treatment for Children with Upper Respiratory Infection (URI)",
        Measure_ID: 65,
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "67.74 - 80.76",
        Decile_4: "80.77 - 91.07",
        Decile_5: "91.08 - 94.74",
        Decile_6: "94.75 - 99.99",
        Decile_7: "--",
        Decile_8: "--",
        Decile_9: "--",
        Decile_10: 100
    },
    {
        Measure_Name: "Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy",
        Measure_ID: 326,
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "20.00 - 39.18",
        Decile_4: "39.19 - 52.33",
        Decile_5: "52.34 - 69.56",
        Decile_6: "69.57 - 76.18",
        Decile_7: "76.19 - 82.49",
        Decile_8: "82.50 - 94.33",
        Decile_9: "94.34 - 99.99",
        Decile_10: 100
    },
    {
        Measure_Name: "Avoid Head CT in Patients with Uncomplicated Syncope",
        Measure_ID: "ECPR 18",
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "74.00 - 78.78",
        Decile_4: "78.79 - 82.60",
        Decile_5: "82.61 - 86.04",
        Decile_6: "86.05 - 88.36",
        Decile_7: "88.37 - 90.90",
        Decile_8: "90.91 - 93.32",
        Decile_9: "93.33 - 96.29",
        Decile_10: ">= 96.30"
    },
    {
        Measure_Name: "Avoid Imaging with X-Rays in Non-traumatic Low Back Pain",
        Measure_ID: "ECPR 21",
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "85.00 - 89.99",
        Decile_4: "90.00 - 91.99",
        Decile_5: "92.00 - 94.51",
        Decile_6: "94.52 - 95.64",
        Decile_7: "95.65 - 97.13",
        Decile_8: "97.14 - 99.99",
        Decile_9: "--",
        Decile_10: 100
    },
    {
        Measure_Name: "Avoiding excessively high tidal volumes during positive pressure ventilation",
        Measure_ID: "ASPIRE 6",
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "89.66 - 91.38",
        Decile_4: "91.39 - 92.67",
        Decile_5: "92.68 - 94.06",
        Decile_6: "94.07 - 95.28",
        Decile_7: "95.29 - 95.46",
        Decile_8: "95.47 - 95.97",
        Decile_9: "95.98 - 96.54",
        Decile_10: ">= 96.55"
    },
    {
        Measure_Name: "Avoiding gaps in systolic or mean arterial pressure measurement",
        Measure_ID: "ASPIRE 17",
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "77.59 - 80.74",
        Decile_4: "80.75 - 90.44",
        Decile_5: "90.45 - 91.11",
        Decile_6: "91.12 - 92.21",
        Decile_7: "92.22 - 92.89",
        Decile_8: "92.90 - 93.71",
        Decile_9: "93.72 - 94.86",
        Decile_10: ">= 94.87"
    },
    {
        Measure_Name: "Avoiding medication overdose",
        Measure_ID: "ASPIRE 22",
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Outcome",
        Benchmark: "Y",
        Decile_3: "99.76 - 99.70",
        Decile_4: "99.69 - 99.65",
        Decile_5: "99.64 - 99.51",
        Decile_6: "99.50 - 99.39",
        Decile_7: "99.38 - 99.32",
        Decile_8: "99.31 - 99.30",
        Decile_9: "99.29 - 98.92",
        Decile_10: "<= 98.91"
    },
    {
        Measure_Name: "Avoiding myocardial Injury",
        Measure_ID: "ASPIRE 18",
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Outcome",
        Benchmark: "Y",
        Decile_3: "99.67 - 99.48",
        Decile_4: "99.47 - 99.43",
        Decile_5: "99.42 - 99.38",
        Decile_6: "99.37 - 99.28",
        Decile_7: "99.27 - 99.02",
        Decile_8: "99.01 - 98.83",
        Decile_9: "98.82 - 98.49",
        Decile_10: "<= 98.48"
    },
    {
        Measure_Name: "Breast Cancer Screening",
        Measure_ID: 112,
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "14.49 - 24.52",
        Decile_4: "24.53 - 35.70",
        Decile_5: "35.71 - 46.01",
        Decile_6: "46.02 - 55.06",
        Decile_7: "55.07 - 63.67",
        Decile_8: "63.68 - 74.06",
        Decile_9: "74.07 - 87.92",
        Decile_10: ">= 87.93"
    },
    {
        Measure_Name: "Breast Cancer Screening",
        Measure_ID: 112,
        Submission_Method: "EHR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "12.41 - 22.21",
        Decile_4: "22.22 - 32.30",
        Decile_5: "32.31 - 40.86",
        Decile_6: "40.87 - 47.91",
        Decile_7: "47.92 - 55.25",
        Decile_8: "55.26 - 63.06",
        Decile_9: "63.07 - 73.22",
        Decile_10: ">= 73.23"
    },
    {
        Measure_Name: "Breast Cancer Screening",
        Measure_ID: "PPRNET 17",
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "20.80 - 29.40",
        Decile_4: "29.41 - 39.74",
        Decile_5: "39.75 - 50.76",
        Decile_6: "50.77 - 57.78",
        Decile_7: "57.79 - 65.44",
        Decile_8: "65.45 - 72.74",
        Decile_9: "72.75 - 82.98",
        Decile_10: ">= 82.99"
    },
    {
        Measure_Name: "CABG + Valve- Prolonged postoperative length of stay (PLOS)",
        Measure_ID: "STS 3",
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Outcome",
        Benchmark: "Y",
        Decile_3: "18.75 - 13.80",
        Decile_4: "13.79 - 12.51",
        Decile_5: "12.50 - 11.12",
        Decile_6: "11.11 - 9.22",
        Decile_7: "9.21 - 6.53",
        Decile_8: "6.52 - 4.56",
        Decile_9: "4.55 - 3.71",
        Decile_10: "<= 3.70"
    },
    {
        Measure_Name: "CABG- Prolonged postoperative length of stay (PLOS)",
        Measure_ID: "STS 1",
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Outcome",
        Benchmark: "Y",
        Decile_3: "8.42 - 6.59",
        Decile_4: "6.58 - 5.34",
        Decile_5: "5.33 - 4.04",
        Decile_6: "4.03 - 3.34",
        Decile_7: "3.33 - 2.48",
        Decile_8: "2.47 - 1.44",
        Decile_9: "1.43 - 0.01",
        Decile_10: 0
    },
    {
        Measure_Name: "Cataract Surgery: Difference Between Planned and Final Refraction",
        Measure_ID: 389,
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Outcome",
        Benchmark: "Y",
        Decile_3: "66.67 - 88.45",
        Decile_4: "88.46 - 94.11",
        Decile_5: "94.12 - 98.09",
        Decile_6: "98.10 - 99.99",
        Decile_7: "--",
        Decile_8: "--",
        Decile_9: "--",
        Decile_10: 100
    },
    {
        Measure_Name: "Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract Surgery",
        Measure_ID: 191,
        Submission_Method: "EHR",
        Measure_Type: "Outcome",
        Benchmark: "Y",
        Decile_3: "86.61 - 91.42",
        Decile_4: "91.43 - 94.43",
        Decile_5: "94.44 - 96.07",
        Decile_6: "96.08 - 97.35",
        Decile_7: "97.36 - 98.30",
        Decile_8: "98.31 - 99.24",
        Decile_9: "99.25 - 99.99",
        Decile_10: 100
    },
    {
        Measure_Name: "Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract Surgery",
        Measure_ID: 191,
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Outcome",
        Benchmark: "Y",
        Decile_3: "42.89 - 59.56",
        Decile_4: "59.57 - 83.17",
        Decile_5: "83.18 - 91.52",
        Decile_6: "91.53 - 94.84",
        Decile_7: "94.85 - 96.79",
        Decile_8: "96.80 - 99.25",
        Decile_9: "99.26 - 99.99",
        Decile_10: 100
    },
    {
        Measure_Name: "Cataracts: Improvement in Patient's Visual Function within 90 Days Following Cataract Surgery",
        Measure_ID: 303,
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Outcome",
        Benchmark: "Y",
        Decile_3: "5.76 - 9.37",
        Decile_4: "9.38 - 23.80",
        Decile_5: "23.81 - 29.87",
        Decile_6: "29.88 - 43.60",
        Decile_7: "43.61 - 56.69",
        Decile_8: "56.70 - 94.33",
        Decile_9: "94.34 - 99.99",
        Decile_10: 100
    },
    {
        Measure_Name: "Cataracts: Patient Satisfaction within 90 Days Following Cataract Surgery",
        Measure_ID: 304,
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Outcome",
        Benchmark: "Y",
        Decile_3: "5.32 - 7.68",
        Decile_4: "7.69 - 21.69",
        Decile_5: "21.70 - 26.67",
        Decile_6: "26.68 - 39.60",
        Decile_7: "39.61 - 46.60",
        Decile_8: "46.61 - 83.07",
        Decile_9: "83.08 - 99.99",
        Decile_10: 100
    },
    {
        Measure_Name: "Cervical Cancer Screening",
        Measure_ID: 309,
        Submission_Method: "EHR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "8.89 - 15.08",
        Decile_4: "15.09 - 21.79",
        Decile_5: "21.80 - 28.83",
        Decile_6: "28.84 - 36.66",
        Decile_7: "36.67 - 44.99",
        Decile_8: "45.00 - 54.77",
        Decile_9: "54.78 - 68.99",
        Decile_10: ">= 69.00"
    },
    {
        Measure_Name: "Cervical Cancer Screening",
        Measure_ID: 309,
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "28.95 - 35.91",
        Decile_4: "35.92 - 43.02",
        Decile_5: "43.03 - 45.56",
        Decile_6: "45.57 - 49.25",
        Decile_7: "49.26 - 51.40",
        Decile_8: "51.41 - 53.78",
        Decile_9: "53.79 - 59.23",
        Decile_10: ">= 59.24"
    },
    {
        Measure_Name: "Cervical Cancer Screening",
        Measure_ID: "PPRNET 16",
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "20.70 - 27.94",
        Decile_4: "27.95 - 33.74",
        Decile_5: "33.75 - 36.69",
        Decile_6: "36.70 - 40.79",
        Decile_7: "40.80 - 48.04",
        Decile_8: "48.05 - 55.20",
        Decile_9: "55.21 - 68.63",
        Decile_10: ">= 68.64"
    },
    {
        Measure_Name: "Child and Adolescent Major Depressive Disorder (MDD): Suicide Risk Assessment",
        Measure_ID: 382,
        Submission_Method: "EHR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "4.84 - 10.64",
        Decile_4: "10.65 - 16.29",
        Decile_5: "16.30 - 28.56",
        Decile_6: "28.57 - 92.97",
        Decile_7: "92.98 - 98.50",
        Decile_8: "98.51 - 99.33",
        Decile_9: "99.34 - 99.99",
        Decile_10: 100
    },
    {
        Measure_Name: "Childhood Immunization Status",
        Measure_ID: 240,
        Submission_Method: "EHR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "4.76 - 6.51",
        Decile_4: "6.52 - 9.08",
        Decile_5: "9.09 - 13.00",
        Decile_6: "13.01 - 18.17",
        Decile_7: "18.18 - 23.80",
        Decile_8: "23.81 - 29.32",
        Decile_9: "29.33 - 41.66",
        Decile_10: ">= 41.67"
    },
    {
        Measure_Name: "Chlamydia Screening for Women",
        Measure_ID: 310,
        Submission_Method: "EHR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "8.33 - 12.86",
        Decile_4: "12.87 - 18.17",
        Decile_5: "18.18 - 24.99",
        Decile_6: "25.00 - 33.32",
        Decile_7: "33.33 - 39.99",
        Decile_8: "40.00 - 49.99",
        Decile_9: "50.00 - 61.53",
        Decile_10: ">= 61.54"
    },
    {
        Measure_Name: "Chlamydia Screening for Women",
        Measure_ID: 310,
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "6.06 - 7.18",
        Decile_4: "7.19 - 9.08",
        Decile_5: "9.09 - 10.23",
        Decile_6: "10.24 - 11.53",
        Decile_7: "11.54 - 13.78",
        Decile_8: "13.79 - 18.17",
        Decile_9: "18.18 - 20.86",
        Decile_10: ">= 20.87"
    },
    {
        Measure_Name: "Chronic Kidney Disease (CKD): eGFR Monitoring",
        Measure_ID: "PPRNET 13",
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "59.02 - 63.42",
        Decile_4: "63.43 - 66.66",
        Decile_5: "66.67 - 72.34",
        Decile_6: "72.35 - 74.59",
        Decile_7: "74.60 - 78.25",
        Decile_8: "78.26 - 85.05",
        Decile_9: "85.06 - 86.95",
        Decile_10: ">= 86.96"
    },
    {
        Measure_Name: "Chronic Kidney Disease (CKD): Hemoglobin Monitoring",
        Measure_ID: "PPRNET 14",
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "66.67 - 77.26",
        Decile_4: "77.27 - 83.86",
        Decile_5: "83.87 - 87.49",
        Decile_6: "87.50 - 88.63",
        Decile_7: "88.64 - 90.47",
        Decile_8: "90.48 - 91.66",
        Decile_9: "91.67 - 93.74",
        Decile_10: ">= 93.75"
    },
    {
        Measure_Name: "Chronic Obstructive Pulmonary Disease (COPD): Spirometry Evaluation",
        Measure_ID: 51,
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "50.53 - 58.59",
        Decile_4: "58.60 - 69.43",
        Decile_5: "69.44 - 77.97",
        Decile_6: "77.98 - 86.43",
        Decile_7: "86.44 - 93.17",
        Decile_8: "93.18 - 97.65",
        Decile_9: "97.66 - 99.99",
        Decile_10: 100
    },
    {
        Measure_Name: "Closing the Referral Loop: Receipt of Specialist Report",
        Measure_ID: 374,
        Submission_Method: "EHR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "2.70 - 6.24",
        Decile_4: "6.25 - 11.46",
        Decile_5: "11.47 - 18.15",
        Decile_6: "18.16 - 25.57",
        Decile_7: "25.58 - 36.95",
        Decile_8: "36.96 - 51.17",
        Decile_9: "51.18 - 71.87",
        Decile_10: ">= 71.88"
    },
    {
        Measure_Name: "Coagulation Studies in Patients Presenting with Chest Pain with No Coagulopathy or Bleeding",
        Measure_ID: "ACEP 3",
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "92.79 - 89.91",
        Decile_4: "89.90 - 87.35",
        Decile_5: "87.34 - 61.63",
        Decile_6: "61.62 - 52.01",
        Decile_7: "52.00 - 42.23",
        Decile_8: "42.22 - 31.98",
        Decile_9: "31.97 - 27.10",
        Decile_10: "<= 27.09"
    },
    {
        Measure_Name: "Coagulation Studies in Patients Presenting with Chest Pain with No Coagulopathy or Bleeding",
        Measure_ID: "ECPR 28",
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "57.93 - 68.03",
        Decile_4: "68.04 - 77.54",
        Decile_5: "77.55 - 83.03",
        Decile_6: "83.04 - 86.89",
        Decile_7: "86.90 - 89.99",
        Decile_8: "90.00 - 93.03",
        Decile_9: "93.04 - 95.61",
        Decile_10: ">= 95.62"
    },
    {
        Measure_Name: "Colorectal Cancer Screening",
        Measure_ID: 113,
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "10.08 - 20.68",
        Decile_4: "20.69 - 32.73",
        Decile_5: "32.74 - 45.20",
        Decile_6: "45.21 - 55.95",
        Decile_7: "55.96 - 66.31",
        Decile_8: "66.32 - 77.01",
        Decile_9: "77.02 - 88.14",
        Decile_10: ">= 88.15"
    },
    {
        Measure_Name: "Colorectal Cancer Screening",
        Measure_ID: 113,
        Submission_Method: "EHR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "7.35 - 15.97",
        Decile_4: "15.98 - 24.66",
        Decile_5: "24.67 - 33.45",
        Decile_6: "33.46 - 44.39",
        Decile_7: "44.40 - 56.19",
        Decile_8: "56.20 - 67.91",
        Decile_9: "67.92 - 82.28",
        Decile_10: ">= 82.29"
    },
    {
        Measure_Name: "Colorectal Cancer screening",
        Measure_ID: "PPRNET 18",
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "40.00 - 44.33",
        Decile_4: "44.34 - 54.80",
        Decile_5: "54.81 - 59.34",
        Decile_6: "59.35 - 61.18",
        Decile_7: "61.19 - 71.11",
        Decile_8: "71.12 - 73.54",
        Decile_9: "73.55 - 76.26",
        Decile_10: ">= 76.27"
    },
    {
        Measure_Name: "Concordance with ACC/AHA Cholesterol Guidelines for ASCVD Risk Reduction",
        Measure_ID: "PPRNET 6",
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "21.33 - 22.10",
        Decile_4: "22.11 - 23.97",
        Decile_5: "23.98 - 24.65",
        Decile_6: "24.66 - 25.83",
        Decile_7: "25.84 - 26.99",
        Decile_8: "27.00 - 31.32",
        Decile_9: "31.33 - 48.65",
        Decile_10: ">= 48.66"
    },
    {
        Measure_Name: "Controlling High Blood Pressure",
        Measure_ID: 236,
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "51.00 - 58.20",
        Decile_4: "58.21 - 63.56",
        Decile_5: "63.57 - 68.27",
        Decile_6: "68.28 - 72.40",
        Decile_7: "72.41 - 76.69",
        Decile_8: "76.70 - 82.75",
        Decile_9: "82.76 - 91.06",
        Decile_10: ">= 91.07"
    },
    {
        Measure_Name: "Controlling High Blood Pressure",
        Measure_ID: 236,
        Submission_Method: "EHR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "50.00 - 55.39",
        Decile_4: "55.40 - 59.72",
        Decile_5: "59.73 - 63.59",
        Decile_6: "63.60 - 67.38",
        Decile_7: "67.39 - 71.00",
        Decile_8: "71.01 - 75.33",
        Decile_9: "75.34 - 80.89",
        Decile_10: ">= 80.90"
    },
    {
        Measure_Name: "Coronary Artery Bypass Graft (CABG): Prolonged Intubation",
        Measure_ID: 164,
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Outcome",
        Benchmark: "Y",
        Decile_3: "12.16 - 10.65",
        Decile_4: "10.64 - 9.29",
        Decile_5: "9.28 - 7.56",
        Decile_6: "7.55 - 6.30",
        Decile_7: "6.29 - 4.97",
        Decile_8: "4.96 - 3.59",
        Decile_9: "3.58 - 1.83",
        Decile_10: "<= 1.82"
    },
    {
        Measure_Name: "Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVEF < 40%)",
        Measure_ID: 118,
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "71.03 - 74.18",
        Decile_4: "74.19 - 76.51",
        Decile_5: "76.52 - 78.94",
        Decile_6: "78.95 - 81.10",
        Decile_7: "81.11 - 83.99",
        Decile_8: "84.00 - 87.79",
        Decile_9: "87.80 - 95.99",
        Decile_10: ">= 96.00"
    },
    {
        Measure_Name: "Coronary Artery Disease (CAD): Antiplatelet Therapy",
        Measure_ID: 6,
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "76.92 - 81.75",
        Decile_4: "81.76 - 84.99",
        Decile_5: "85.00 - 87.53",
        Decile_6: "87.54 - 90.22",
        Decile_7: "90.23 - 92.54",
        Decile_8: "92.55 - 95.64",
        Decile_9: "95.65 - 99.99",
        Decile_10: 100
    },
    {
        Measure_Name: "Coronary Artery Disease (CAD): Beta-Blocker Therapy - Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF < 40%)",
        Measure_ID: 7,
        Submission_Method: "EHR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "61.21 - 71.99",
        Decile_4: "72.00 - 76.62",
        Decile_5: "76.63 - 80.76",
        Decile_6: "80.77 - 84.00",
        Decile_7: "84.01 - 88.88",
        Decile_8: "88.89 - 92.65",
        Decile_9: "92.66 - 98.14",
        Decile_10: ">= 98.15"
    },
    {
        Measure_Name: "Coronary Artery Disease (CAD): Beta-Blocker Therapy - Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF < 40%)",
        Measure_ID: 7,
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "74.51 - 78.56",
        Decile_4: "78.57 - 81.51",
        Decile_5: "81.52 - 84.53",
        Decile_6: "84.54 - 86.97",
        Decile_7: "86.98 - 89.35",
        Decile_8: "89.36 - 92.58",
        Decile_9: "92.59 - 97.91",
        Decile_10: ">= 97.92"
    },
    {
        Measure_Name: "Coronary Artery Disease (CAD): Blood Pressure Control",
        Measure_ID: "ACCPin 2",
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Outcome",
        Benchmark: "Y",
        Decile_3: "81.51 - 85.87",
        Decile_4: "85.88 - 88.51",
        Decile_5: "88.52 - 90.49",
        Decile_6: "90.50 - 91.71",
        Decile_7: "91.72 - 92.90",
        Decile_8: "92.91 - 94.15",
        Decile_9: "94.16 - 95.53",
        Decile_10: ">= 95.54"
    },
    {
        Measure_Name: "Dementia: Cognitive Assessment",
        Measure_ID: 281,
        Submission_Method: "EHR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "5.66 - 17.56",
        Decile_4: "17.57 - 30.76",
        Decile_5: "30.77 - 56.25",
        Decile_6: "56.26 - 78.05",
        Decile_7: "78.06 - 88.13",
        Decile_8: "88.14 - 95.55",
        Decile_9: "95.56 - 99.99",
        Decile_10: 100
    },
    {
        Measure_Name: "Depression Screening",
        Measure_ID: "PPRNET 21",
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "14.03 - 19.70",
        Decile_4: "19.71 - 32.75",
        Decile_5: "32.76 - 41.56",
        Decile_6: "41.57 - 46.42",
        Decile_7: "46.43 - 64.00",
        Decile_8: "64.01 - 78.68",
        Decile_9: "78.69 - 83.73",
        Decile_10: ">= 83.74"
    },
    {
        Measure_Name: "Depression Utilization of the PHQ-9 Tool",
        Measure_ID: 371,
        Submission_Method: "EHR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "1.38 - 1.95",
        Decile_4: "1.96 - 2.91",
        Decile_5: "2.92 - 4.29",
        Decile_6: "4.30 - 6.81",
        Decile_7: "6.82 - 12.23",
        Decile_8: "12.24 - 21.20",
        Decile_9: "21.21 - 52.62",
        Decile_10: ">= 52.63"
    },
    {
        Measure_Name: "Depression Utilization of the PHQ-9 Tool",
        Measure_ID: 371,
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "0.27 - 0.34",
        Decile_4: "0.35 - 0.39",
        Decile_5: "0.40 - 0.52",
        Decile_6: "0.53 - 0.60",
        Decile_7: "0.61 - 0.75",
        Decile_8: "0.76 - 0.89",
        Decile_9: "0.90 - 1.43",
        Decile_10: ">= 1.44"
    },
    {
        Measure_Name: "Diabetes Mellitus (DM): Dilated Eye Exam",
        Measure_ID: "PPRNET 3",
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "8.64 - 13.21",
        Decile_4: "13.22 - 18.97",
        Decile_5: "18.98 - 27.26",
        Decile_6: "27.27 - 31.86",
        Decile_7: "31.87 - 41.66",
        Decile_8: "41.67 - 46.96",
        Decile_9: "46.97 - 57.44",
        Decile_10: ">= 57.45"
    },
    {
        Measure_Name: "Diabetes Mellitus (DM): Hemoglobin A1c Control (< 8%)",
        Measure_ID: "PPRNET 1",
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Outcome",
        Benchmark: "Y",
        Decile_3: "62.69 - 64.28",
        Decile_4: "64.29 - 65.90",
        Decile_5: "65.91 - 68.23",
        Decile_6: "68.24 - 69.99",
        Decile_7: "70.00 - 70.49",
        Decile_8: "70.50 - 71.66",
        Decile_9: "71.67 - 74.99",
        Decile_10: ">= 75.00"
    },
    {
        Measure_Name: "Diabetes Mellitus (DM): Nephropathy Assessment",
        Measure_ID: "PPRNET 2",
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "74.07 - 80.64",
        Decile_4: "80.65 - 84.29",
        Decile_5: "84.30 - 85.22",
        Decile_6: "85.23 - 87.20",
        Decile_7: "87.21 - 88.45",
        Decile_8: "88.46 - 90.51",
        Decile_9: "90.52 - 91.66",
        Decile_10: ">= 91.67"
    },
    {
        Measure_Name: "Diabetes Mellitus: Diabetic Foot and Ankle Care, Peripheral Neuropathy - Neurological Evaluation",
        Measure_ID: 126,
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "10.34 - 18.46",
        Decile_4: "18.47 - 28.94",
        Decile_5: "28.95 - 41.66",
        Decile_6: "41.67 - 60.23",
        Decile_7: "60.24 - 75.20",
        Decile_8: "75.21 - 89.89",
        Decile_9: "89.90 - 99.99",
        Decile_10: 100
    },
    {
        Measure_Name: "Diabetes Mellitus: Diabetic Foot and Ankle Care, Ulcer Prevention - Evaluation of Footwear",
        Measure_ID: 127,
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "4.26 - 11.10",
        Decile_4: "11.11 - 22.80",
        Decile_5: "22.81 - 39.99",
        Decile_6: "40.00 - 61.69",
        Decile_7: "61.70 - 79.56",
        Decile_8: "79.57 - 93.74",
        Decile_9: "93.75 - 99.99",
        Decile_10: 100
    },
    {
        Measure_Name: "Diabetes: Eye Exam",
        Measure_ID: 117,
        Submission_Method: "EHR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "50.57 - 80.68",
        Decile_4: "80.69 - 90.05",
        Decile_5: "90.06 - 94.11",
        Decile_6: "94.12 - 96.66",
        Decile_7: "96.67 - 98.57",
        Decile_8: "98.58 - 99.99",
        Decile_9: "--",
        Decile_10: 100
    },
    {
        Measure_Name: "Diabetes: Foot Exam",
        Measure_ID: 163,
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "6.14 - 14.70",
        Decile_4: "14.71 - 25.57",
        Decile_5: "25.58 - 39.80",
        Decile_6: "39.81 - 55.87",
        Decile_7: "55.88 - 72.21",
        Decile_8: "72.22 - 86.43",
        Decile_9: "86.44 - 98.03",
        Decile_10: ">= 98.04"
    },
    {
        Measure_Name: "Diabetes: Foot Exam",
        Measure_ID: 163,
        Submission_Method: "EHR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "5.31 - 10.90",
        Decile_4: "10.91 - 19.99",
        Decile_5: "20.00 - 29.26",
        Decile_6: "29.27 - 38.77",
        Decile_7: "38.78 - 50.09",
        Decile_8: "50.10 - 62.60",
        Decile_9: "62.61 - 76.16",
        Decile_10: ">= 76.17"
    },
    {
        Measure_Name: "Diabetes: Hemoglobin A1c Poor Control",
        Measure_ID: 1,
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Outcome",
        Benchmark: "Y",
        Decile_3: "83.10 - 68.19",
        Decile_4: "68.18 - 53.14",
        Decile_5: "53.13 - 40.66",
        Decile_6: "40.65 - 30.20",
        Decile_7: "30.19 - 22.74",
        Decile_8: "22.73 - 16.82",
        Decile_9: "16.81 - 10.33",
        Decile_10: "<= 10.32"
    },
    {
        Measure_Name: "Diabetes: Hemoglobin A1c Poor Control",
        Measure_ID: 1,
        Submission_Method: "EHR",
        Measure_Type: "Outcome",
        Benchmark: "Y",
        Decile_3: "54.67 - 35.91",
        Decile_4: "35.90 - 25.63",
        Decile_5: "25.62 - 19.34",
        Decile_6: "19.33 - 14.15",
        Decile_7: "14.14 - 9.10",
        Decile_8: "9.09 - 3.34",
        Decile_9: "3.33 - 0.01",
        Decile_10: 0
    },
    {
        Measure_Name: "Diabetes: Low Density Lipoprotein (LDL-C) Control (<100 mg/dL)",
        Measure_ID: 2,
        Submission_Method: "EHR",
        Measure_Type: "Outcome",
        Benchmark: "Y",
        Decile_3: "20.83 - 29.47",
        Decile_4: "29.48 - 35.99",
        Decile_5: "36.00 - 42.44",
        Decile_6: "42.45 - 48.17",
        Decile_7: "48.18 - 54.03",
        Decile_8: "54.04 - 60.33",
        Decile_9: "60.34 - 69.35",
        Decile_10: ">= 69.36"
    },
    {
        Measure_Name: "Diabetes: Low Density Lipoprotein (LDL-C) Control (<100 mg/dL)",
        Measure_ID: 2,
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Outcome",
        Benchmark: "Y",
        Decile_3: "0.83 - 1.06",
        Decile_4: "1.07 - 1.35",
        Decile_5: "1.36 - 1.82",
        Decile_6: "1.83 - 2.51",
        Decile_7: "2.52 - 3.53",
        Decile_8: "3.54 - 6.45",
        Decile_9: "6.46 - 25.57",
        Decile_10: ">= 25.58"
    },
    {
        Measure_Name: "Diabetes: Medical Attention for Nephropathy",
        Measure_ID: 119,
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "66.24 - 73.41",
        Decile_4: "73.42 - 79.16",
        Decile_5: "79.17 - 83.01",
        Decile_6: "83.02 - 86.95",
        Decile_7: "86.96 - 90.47",
        Decile_8: "90.48 - 94.51",
        Decile_9: "94.52 - 99.70",
        Decile_10: ">= 99.71"
    },
    {
        Measure_Name: "Diabetes: Medical Attention for Nephropathy",
        Measure_ID: 119,
        Submission_Method: "EHR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "66.67 - 72.91",
        Decile_4: "72.92 - 78.12",
        Decile_5: "78.13 - 82.26",
        Decile_6: "82.27 - 86.12",
        Decile_7: "86.13 - 89.95",
        Decile_8: "89.96 - 93.32",
        Decile_9: "93.33 - 96.63",
        Decile_10: ">= 96.64"
    },
    {
        Measure_Name: "Diabetic Foot & Ankle Care: Comprehensive Diabetic Foot Examination",
        Measure_ID: "CDR 4",
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "13.04 - 16.21",
        Decile_4: "16.22 - 22.02",
        Decile_5: "22.03 - 25.62",
        Decile_6: "25.63 - 31.02",
        Decile_7: "31.03 - 33.32",
        Decile_8: "33.33 - 35.99",
        Decile_9: "36.00 - 41.66",
        Decile_10: ">= 41.67"
    },
    {
        Measure_Name: "Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care",
        Measure_ID: 19,
        Submission_Method: "EHR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "20.00 - 29.78",
        Decile_4: "29.79 - 38.35",
        Decile_5: "38.36 - 45.70",
        Decile_6: "45.71 - 52.53",
        Decile_7: "52.54 - 60.79",
        Decile_8: "60.80 - 68.80",
        Decile_9: "68.81 - 79.30",
        Decile_10: ">= 79.31"
    },
    {
        Measure_Name: "Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care",
        Measure_ID: 19,
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "36.21 - 59.99",
        Decile_4: "60.00 - 78.56",
        Decile_5: "78.57 - 89.80",
        Decile_6: "89.81 - 96.22",
        Decile_7: "96.23 - 99.99",
        Decile_8: "--",
        Decile_9: "--",
        Decile_10: 100
    },
    {
        Measure_Name: "Diabetic Retinopathy: Documentation of Presence or Absence of Macular Edema and Level of Severity of Retinopathy",
        Measure_ID: 18,
        Submission_Method: "EHR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "31.69 - 41.32",
        Decile_4: "41.33 - 49.99",
        Decile_5: "50.00 - 56.97",
        Decile_6: "56.98 - 64.17",
        Decile_7: "64.18 - 70.58",
        Decile_8: "70.59 - 76.97",
        Decile_9: "76.98 - 85.15",
        Decile_10: ">= 85.16"
    },
    {
        Measure_Name: "Disease Activity Measurement for Patients with Rheumatoid Arthritis (RA)",
        Measure_ID: "ACR 1",
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "45.52 - 70.28",
        Decile_4: "70.29 - 76.05",
        Decile_5: "76.06 - 86.10",
        Decile_6: "86.11 - 92.41",
        Decile_7: "92.42 - 99.25",
        Decile_8: "99.26 - 99.99",
        Decile_9: "--",
        Decile_10: 100
    },
    {
        Measure_Name: "Disease-Modifying Anti-Rheumatic Drug (DMARD) Therapy for Active Rheumatoid Arthritis (RA)",
        Measure_ID: "ACR 3",
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "86.10 - 88.31",
        Decile_4: "88.32 - 90.60",
        Decile_5: "90.61 - 92.79",
        Decile_6: "92.80 - 94.04",
        Decile_7: "94.05 - 94.91",
        Decile_8: "94.92 - 96.29",
        Decile_9: "96.30 - 97.48",
        Decile_10: ">= 97.49"
    },
    {
        Measure_Name: "Elder Maltreatment Screen and Follow-Up Plan",
        Measure_ID: 181,
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "28.80 - 42.30",
        Decile_4: "42.31 - 51.95",
        Decile_5: "51.96 - 67.46",
        Decile_6: "67.47 - 85.94",
        Decile_7: "85.95 - 97.24",
        Decile_8: "97.25 - 99.65",
        Decile_9: "99.66 - 99.99",
        Decile_10: 100
    },
    {
        Measure_Name: "Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older",
        Measure_ID: "ECPR 19",
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "46.15 - 57.13",
        Decile_4: "57.14 - 65.37",
        Decile_5: "65.38 - 70.89",
        Decile_6: "70.90 - 79.99",
        Decile_7: "80.00 - 85.70",
        Decile_8: "85.71 - 89.99",
        Decile_9: "90.00 - 95.23",
        Decile_10: ">= 95.24"
    },
    {
        Measure_Name: "Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 2 to 17 Years",
        Measure_ID: "ECPR 20",
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "78.26 - 86.83",
        Decile_4: "86.84 - 93.32",
        Decile_5: "93.33 - 94.28",
        Decile_6: "94.29 - 94.99",
        Decile_7: "95.00 - 96.87",
        Decile_8: "96.88 - 99.99",
        Decile_9: "--",
        Decile_10: 100
    },
    {
        Measure_Name: "Falls: Plan of Care",
        Measure_ID: 155,
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "20.00 - 41.43",
        Decile_4: "41.44 - 62.11",
        Decile_5: "62.12 - 75.44",
        Decile_6: "75.45 - 85.99",
        Decile_7: "86.00 - 93.32",
        Decile_8: "93.33 - 98.07",
        Decile_9: "98.08 - 99.99",
        Decile_10: 100
    },
    {
        Measure_Name: "Falls: Risk Assessment",
        Measure_ID: 154,
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "7.81 - 19.99",
        Decile_4: "20.00 - 38.12",
        Decile_5: "38.13 - 57.62",
        Decile_6: "57.63 - 84.16",
        Decile_7: "84.17 - 99.82",
        Decile_8: "99.83 - 99.99",
        Decile_9: "--",
        Decile_10: 100
    },
    {
        Measure_Name: "Falls: Screening for Future Fall Risk",
        Measure_ID: 318,
        Submission_Method: "EHR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "6.33 - 17.92",
        Decile_4: "17.93 - 31.98",
        Decile_5: "31.99 - 47.86",
        Decile_6: "47.87 - 63.81",
        Decile_7: "63.82 - 81.04",
        Decile_8: "81.05 - 90.20",
        Decile_9: "90.21 - 98.49",
        Decile_10: ">= 98.50"
    },
    {
        Measure_Name: "Falls: Screening for Future Fall Risk",
        Measure_ID: 318,
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "0.11 - 0.11",
        Decile_4: "0.12 - 0.14",
        Decile_5: "0.15 - 0.20",
        Decile_6: "0.21 - 0.28",
        Decile_7: "0.29 - 0.50",
        Decile_8: "0.51 - 55.23",
        Decile_9: "55.24 - 92.20",
        Decile_10: ">= 92.21"
    },
    {
        Measure_Name: "Follow-up After Hospitalization for Mental Illness (FUH)",
        Measure_ID: 391,
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "3.81 - 13.63",
        Decile_4: "13.64 - 17.48",
        Decile_5: "17.49 - 46.63",
        Decile_6: "46.64 - 72.33",
        Decile_7: "72.34 - 99.99",
        Decile_8: "--",
        Decile_9: "--",
        Decile_10: 100
    },
    {
        Measure_Name: "Functional Status Assessment for Knee Replacement",
        Measure_ID: 375,
        Submission_Method: "EHR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "5.36 - 9.51",
        Decile_4: "9.52 - 9.99",
        Decile_5: "10.00 - 43.95",
        Decile_6: "43.96 - 47.82",
        Decile_7: "47.83 - 54.54",
        Decile_8: "54.55 - 66.04",
        Decile_9: "66.05 - 85.18",
        Decile_10: ">= 85.19"
    },
    {
        Measure_Name: "Functional Status Assessment for Patients with Rheumatoid Arthritis (RA)",
        Measure_ID: "ACR 2",
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "42.02 - 62.49",
        Decile_4: "62.50 - 71.04",
        Decile_5: "71.05 - 80.78",
        Decile_6: "80.79 - 86.22",
        Decile_7: "86.23 - 91.68",
        Decile_8: "91.69 - 98.00",
        Decile_9: "98.01 - 99.99",
        Decile_10: 100
    },
    {
        Measure_Name: "Glucocorticosteroids and Other Secondary Causes",
        Measure_ID: "ACR 5",
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "52.44 - 55.80",
        Decile_4: "55.81 - 63.74",
        Decile_5: "63.75 - 71.67",
        Decile_6: "71.68 - 77.60",
        Decile_7: "77.61 - 84.90",
        Decile_8: "84.91 - 88.88",
        Decile_9: "88.89 - 94.19",
        Decile_10: ">= 94.20"
    },
    {
        Measure_Name: "Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD)",
        Measure_ID: 5,
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "75.86 - 79.48",
        Decile_4: "79.49 - 82.13",
        Decile_5: "82.14 - 84.99",
        Decile_6: "85.00 - 87.49",
        Decile_7: "87.50 - 89.99",
        Decile_8: "90.00 - 93.53",
        Decile_9: "93.54 - 96.54",
        Decile_10: ">= 96.55"
    },
    {
        Measure_Name: "Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD)",
        Measure_ID: 5,
        Submission_Method: "EHR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "62.16 - 66.66",
        Decile_4: "66.67 - 71.42",
        Decile_5: "71.43 - 74.90",
        Decile_6: "74.91 - 77.60",
        Decile_7: "77.61 - 82.60",
        Decile_8: "82.61 - 85.70",
        Decile_9: "85.71 - 90.90",
        Decile_10: ">= 90.91"
    },
    {
        Measure_Name: "Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)",
        Measure_ID: 8,
        Submission_Method: "EHR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "58.62 - 64.70",
        Decile_4: "64.71 - 71.94",
        Decile_5: "71.95 - 78.25",
        Decile_6: "78.26 - 85.50",
        Decile_7: "85.51 - 89.99",
        Decile_8: "90.00 - 91.66",
        Decile_9: "91.67 - 95.99",
        Decile_10: ">= 96.00"
    },
    {
        Measure_Name: "Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)",
        Measure_ID: 8,
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "75.68 - 81.07",
        Decile_4: "81.08 - 85.57",
        Decile_5: "85.58 - 88.43",
        Decile_6: "88.44 - 91.16",
        Decile_7: "91.17 - 94.28",
        Decile_8: "94.29 - 96.36",
        Decile_9: "96.37 - 99.99",
        Decile_10: 100
    },
    {
        Measure_Name: "Hepatitis C: One-Time Screening for Hepatitis C Virus (HCV) for Patients at Risk",
        Measure_ID: 400,
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "1.19 - 1.33",
        Decile_4: "1.34 - 1.53",
        Decile_5: "1.54 - 1.71",
        Decile_6: "1.72 - 2.09",
        Decile_7: "2.10 - 2.92",
        Decile_8: "2.93 - 8.32",
        Decile_9: "8.33 - 20.01",
        Decile_10: ">= 20.02"
    },
    {
        Measure_Name: "HIV/AIDS: Medical Visit",
        Measure_ID: 368,
        Submission_Method: "EHR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "45.21 - 53.67",
        Decile_4: "53.68 - 59.99",
        Decile_5: "60.00 - 68.05",
        Decile_6: "68.06 - 74.99",
        Decile_7: "75.00 - 80.99",
        Decile_8: "81.00 - 89.57",
        Decile_9: "89.58 - 96.66",
        Decile_10: ">= 96.67"
    },
    {
        Measure_Name: "HIV/AIDS: RNA Control for Patients with HIV",
        Measure_ID: 381,
        Submission_Method: "EHR",
        Measure_Type: "Outcome",
        Benchmark: "Y",
        Decile_3: "19.47 - 27.84",
        Decile_4: "27.85 - 33.42",
        Decile_5: "33.43 - 42.85",
        Decile_6: "42.86 - 76.26",
        Decile_7: "76.27 - 84.99",
        Decile_8: "85.00 - 90.31",
        Decile_9: "90.32 - 92.49",
        Decile_10: ">= 92.50"
    },
    {
        Measure_Name: "Hypertension (HTN): Appropriate Diagnosis",
        Measure_ID: "PPRNET 4",
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "80.36 - 80.98",
        Decile_4: "80.99 - 84.54",
        Decile_5: "84.55 - 88.13",
        Decile_6: "88.14 - 89.50",
        Decile_7: "89.51 - 90.19",
        Decile_8: "90.20 - 92.58",
        Decile_9: "92.59 - 93.17",
        Decile_10: ">= 93.18"
    },
    {
        Measure_Name: "Hypertension (HTN): Blood Pressure (BP) Management",
        Measure_ID: "ACCPin 1",
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "80.04 - 84.15",
        Decile_4: "84.16 - 86.65",
        Decile_5: "86.66 - 88.55",
        Decile_6: "88.56 - 89.84",
        Decile_7: "89.85 - 91.05",
        Decile_8: "91.06 - 92.34",
        Decile_9: "92.35 - 93.89",
        Decile_10: ">= 93.90"
    },
    {
        Measure_Name: "Hypertension (HTN): Controlling Blood Pressure",
        Measure_ID: "PPRNET 5",
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Outcome",
        Benchmark: "Y",
        Decile_3: "59.10 - 61.02",
        Decile_4: "61.03 - 63.26",
        Decile_5: "63.27 - 64.74",
        Decile_6: "64.75 - 67.04",
        Decile_7: "67.05 - 68.86",
        Decile_8: "68.87 - 71.92",
        Decile_9: "71.93 - 75.11",
        Decile_10: ">= 75.12"
    },
    {
        Measure_Name: "Hypertension: Improvement in Blood Pressure",
        Measure_ID: 373,
        Submission_Method: "EHR",
        Measure_Type: "Outcome",
        Benchmark: "Y",
        Decile_3: "6.82 - 9.31",
        Decile_4: "9.32 - 11.70",
        Decile_5: "11.71 - 14.40",
        Decile_6: "14.41 - 17.39",
        Decile_7: "17.40 - 21.44",
        Decile_8: "21.45 - 27.61",
        Decile_9: "27.62 - 39.04",
        Decile_10: ">= 39.05"
    },
    {
        Measure_Name: "Hypertension: Improvement in Blood Pressure",
        Measure_ID: 373,
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Outcome",
        Benchmark: "Y",
        Decile_3: "2.39 - 2.93",
        Decile_4: "2.94 - 3.46",
        Decile_5: "3.47 - 3.92",
        Decile_6: "3.93 - 4.71",
        Decile_7: "4.72 - 5.53",
        Decile_8: "5.54 - 6.74",
        Decile_9: "6.75 - 9.99",
        Decile_10: ">= 10"
    },
    {
        Measure_Name: "Immediate Perioperative Cardiac Arrest Rate",
        Measure_ID: "AQI 6",
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Outcome",
        Benchmark: "Y",
        Decile_3: "0.11 - 0.13",
        Decile_4: "0.14 - 0.18",
        Decile_5: "0.19 - 0.24",
        Decile_6: "0.25 - 0.31",
        Decile_7: "0.32 - 0.50",
        Decile_8: "0.51 - 0.81",
        Decile_9: "0.82 - 1.49",
        Decile_10: ">= 1.50"
    },
    {
        Measure_Name: "Immediate Perioperative Mortality Rate",
        Measure_ID: "AQI 7",
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Outcome",
        Benchmark: "Y",
        Decile_3: "0.10 - 0.13",
        Decile_4: "0.14 - 0.16",
        Decile_5: "0.17 - 0.19",
        Decile_6: "0.20 - 0.23",
        Decile_7: "0.24 - 0.28",
        Decile_8: "0.29 - 0.34",
        Decile_9: "0.35 - 0.60",
        Decile_10: ">= 0.61"
    },
    {
        Measure_Name: "Initiation and Engagement of Alcohol and Other Drug Dependence Treatment",
        Measure_ID: 305,
        Submission_Method: "EHR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "0.71 - 0.94",
        Decile_4: "0.95 - 1.20",
        Decile_5: "1.21 - 2.10",
        Decile_6: "2.11 - 2.49",
        Decile_7: "2.50 - 5.12",
        Decile_8: "5.13 - 6.98",
        Decile_9: "6.99 - 12.05",
        Decile_10: ">= 12.06"
    },
    {
        Measure_Name: "Initiation of the Initial Sepsis Bundle",
        Measure_ID: "ECPR 24",
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "78.57 - 84.61",
        Decile_4: "84.62 - 88.88",
        Decile_5: "88.89 - 91.73",
        Decile_6: "91.74 - 94.99",
        Decile_7: "95.00 - 96.29",
        Decile_8: "96.30 - 97.72",
        Decile_9: "97.73 - 99.99",
        Decile_10: 100
    },
    {
        Measure_Name: "Ischemic Vascular Disease (IVD): Complete Lipid Profile and LDL-C Control (<100 mg/dL)",
        Measure_ID: 241,
        Submission_Method: "EHR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "21.62 - 35.70",
        Decile_4: "35.71 - 46.33",
        Decile_5: "46.34 - 53.95",
        Decile_6: "53.96 - 60.37",
        Decile_7: "60.38 - 66.51",
        Decile_8: "66.52 - 73.39",
        Decile_9: "73.40 - 81.89",
        Decile_10: ">= 81.90"
    },
    {
        Measure_Name: "Ischemic Vascular Disease (IVD): Complete Lipid Profile and LDL-C Control (<100 mg/dL)",
        Measure_ID: 241,
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "15.56 - 17.74",
        Decile_4: "17.75 - 19.55",
        Decile_5: "19.56 - 22.23",
        Decile_6: "22.24 - 24.76",
        Decile_7: "24.77 - 30.29",
        Decile_8: "30.30 - 34.76",
        Decile_9: "34.77 - 41.75",
        Decile_10: ">= 41.76"
    },
    {
        Measure_Name: "Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic",
        Measure_ID: 204,
        Submission_Method: "EHR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "55.21 - 63.76",
        Decile_4: "63.77 - 69.99",
        Decile_5: "70.00 - 74.99",
        Decile_6: "75.00 - 78.78",
        Decile_7: "78.79 - 81.99",
        Decile_8: "82.00 - 85.03",
        Decile_9: "85.04 - 88.69",
        Decile_10: ">= 88.70"
    },
    {
        Measure_Name: "Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic",
        Measure_ID: 204,
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "68.03 - 75.75",
        Decile_4: "75.76 - 80.76",
        Decile_5: "80.77 - 84.61",
        Decile_6: "84.62 - 87.92",
        Decile_7: "87.93 - 90.94",
        Decile_8: "90.95 - 94.73",
        Decile_9: "94.74 - 99.99",
        Decile_10: 100
    },
    {
        Measure_Name: "Isolated Valve- Prolonged postoperative length of stay (PLOS)",
        Measure_ID: "STS 5",
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Outcome",
        Benchmark: "Y",
        Decile_3: "9.84 - 8.01",
        Decile_4: "8.00 - 6.91",
        Decile_5: "6.90 - 4.89",
        Decile_6: "4.88 - 4.01",
        Decile_7: "4.00 - 3.04",
        Decile_8: "3.03 - 2.34",
        Decile_9: "2.33 - 0.01",
        Decile_10: 0
    },
    {
        Measure_Name: "",
        Measure_ID: "",
        Submission_Method: "",
        Measure_Type: "",
        Benchmark: "",
        Decile_3: "",
        Decile_4: "",
        Decile_5: "",
        Decile_6: "",
        Decile_7: "",
        Decile_8: "",
        Decile_9: "",
        Decile_10: ""
    },
    {
        Measure_Name: "Melanoma: Continuity of Care - Recall System",
        Measure_ID: 137,
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Structure",
        Benchmark: "Y",
        Decile_3: "53.73 - 75.75",
        Decile_4: "75.76 - 88.45",
        Decile_5: "88.46 - 98.07",
        Decile_6: "98.08 - 99.99",
        Decile_7: "--",
        Decile_8: "--",
        Decile_9: "--",
        Decile_10: 100
    },
    {
        Measure_Name: "Monitoring Serum Potassium",
        Measure_ID: "PPRNET 29",
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "82.03 - 82.10",
        Decile_4: "82.11 - 83.01",
        Decile_5: "83.02 - 86.19",
        Decile_6: "86.20 - 88.19",
        Decile_7: "88.20 - 90.90",
        Decile_8: "90.91 - 93.78",
        Decile_9: "93.79 - 96.60",
        Decile_10: ">= 96.61"
    },
    {
        Measure_Name: "Nonexudative Age-Related Macular Degeneration: Loss of Visual Acuity",
        Measure_ID: "IRIS 11",
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Outcome",
        Benchmark: "Y",
        Decile_3: "72.97 - 79.58",
        Decile_4: "79.59 - 85.70",
        Decile_5: "85.71 - 95.58",
        Decile_6: "95.59 - 97.43",
        Decile_7: "97.44 - 99.99",
        Decile_8: "--",
        Decile_9: "--",
        Decile_10: 100
    },
    {
        Measure_Name: "NSAID or Cox 2 Inhibitor Use in Patients with Heart Failure (HF) or Chronic Kidney Disease (CKD)",
        Measure_ID: "PPRNET 28",
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "83.51 - 84.64",
        Decile_4: "84.65 - 85.94",
        Decile_5: "85.95 - 86.97",
        Decile_6: "86.98 - 89.25",
        Decile_7: "89.26 - 89.72",
        Decile_8: "89.73 - 90.32",
        Decile_9: "90.33 - 92.93",
        Decile_10: ">= 92.94"
    },
    {
        Measure_Name: "Nuclear Medicine: Correlation with Existing Imaging Studies for All Patients Undergoing Bone Scintigraphy",
        Measure_ID: 147,
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Structure",
        Benchmark: "Y",
        Decile_3: "59.52 - 71.10",
        Decile_4: "71.11 - 83.09",
        Decile_5: "83.10 - 91.66",
        Decile_6: "91.67 - 96.54",
        Decile_7: "96.55 - 99.33",
        Decile_8: "99.34 - 99.99",
        Decile_9: "--",
        Decile_10: 100
    },
    {
        Measure_Name: "Oncology: Cancer Stage Documented",
        Measure_ID: 194,
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "5.00 - 9.81",
        Decile_4: "9.82 - 23.88",
        Decile_5: "23.89 - 62.49",
        Decile_6: "62.50 - 83.01",
        Decile_7: "83.02 - 94.86",
        Decile_8: "94.87 - 99.82",
        Decile_9: "99.83 - 99.99",
        Decile_10: 100
    },
    {
        Measure_Name: "Oncology: Medical and Radiation - Pain Intensity Quantified",
        Measure_ID: 143,
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "35.53 - 76.18",
        Decile_4: "76.19 - 82.13",
        Decile_5: "82.14 - 90.20",
        Decile_6: "90.21 - 96.76",
        Decile_7: "96.77 - 99.99",
        Decile_8: "--",
        Decile_9: "--",
        Decile_10: 100
    },
    {
        Measure_Name: "Oncology: Medical and Radiation - Plan of Care for Pain",
        Measure_ID: 144,
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "33.64 - 48.19",
        Decile_4: "48.20 - 66.91",
        Decile_5: "66.92 - 78.41",
        Decile_6: "78.42 - 85.83",
        Decile_7: "85.84 - 99.11",
        Decile_8: "99.12 - 99.99",
        Decile_9: "--",
        Decile_10: 100
    },
    {
        Measure_Name: "Orthopedic Pain: Assessment and follow--?up",
        Measure_ID: "OBERD 9",
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "37.51 - 42.78",
        Decile_4: "42.79 - 50.58",
        Decile_5: "50.59 - 53.93",
        Decile_6: "53.94 - 58.28",
        Decile_7: "58.29 - 63.36",
        Decile_8: "63.37 - 66.86",
        Decile_9: "66.87 - 70.96",
        Decile_10: ">= 70.97"
    },
    {
        Measure_Name: "Orthopedic Pain: Mental Health Assessment",
        Measure_ID: "OBERD 6",
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "5.73 - 7.61",
        Decile_4: "7.62 - 10.91",
        Decile_5: "10.92 - 14.51",
        Decile_6: "14.52 - 17.75",
        Decile_7: "17.76 - 21.62",
        Decile_8: "21.63 - 26.97",
        Decile_9: "26.98 - 37.62",
        Decile_10: ">= 37.63"
    },
    {
        Measure_Name: "Osteoarthritis (OA): Function and Pain Assessment",
        Measure_ID: 109,
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "5.16 - 14.84",
        Decile_4: "14.85 - 37.78",
        Decile_5: "37.79 - 65.33",
        Decile_6: "65.34 - 88.04",
        Decile_7: "88.05 - 97.81",
        Decile_8: "97.82 - 99.99",
        Decile_9: "--",
        Decile_10: 100
    },
    {
        Measure_Name: "Osteoporosis Screening for Women",
        Measure_ID: "PPRNET 15",
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "16.80 - 23.69",
        Decile_4: "23.70 - 44.43",
        Decile_5: "44.44 - 53.24",
        Decile_6: "53.25 - 57.62",
        Decile_7: "57.63 - 65.28",
        Decile_8: "65.29 - 68.32",
        Decile_9: "68.33 - 78.64",
        Decile_10: ">= 78.65"
    },
    {
        Measure_Name: "Osteoporosis: Communication with the Physician Managing On-going Care Post-Fracture of Hip, Spine or Distal Radius for Men and Women Aged 50 Years and Older",
        Measure_ID: 24,
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "8.00 - 10.33",
        Decile_4: "10.34 - 12.49",
        Decile_5: "12.50 - 17.06",
        Decile_6: "17.07 - 21.87",
        Decile_7: "21.88 - 49.99",
        Decile_8: "50.00 - 82.49",
        Decile_9: "82.50 - 99.99",
        Decile_10: 100
    },
    {
        Measure_Name: "Osteoporosis: Management Following Fracture of Hip, Spine or Distal Radius for Men and Women Aged 50 Years and Older",
        Measure_ID: 40,
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "5.00 - 6.95",
        Decile_4: "6.96 - 8.69",
        Decile_5: "8.70 - 16.13",
        Decile_6: "16.14 - 32.78",
        Decile_7: "32.79 - 47.40",
        Decile_8: "47.41 - 65.56",
        Decile_9: "65.57 - 88.88",
        Decile_10: ">= 88.89"
    },
    {
        Measure_Name: "Osteoporosis: Pharmacologic Therapy for Men and Women Aged 50 Years and Older",
        Measure_ID: 41,
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "33.33 - 40.43",
        Decile_4: "40.44 - 46.28",
        Decile_5: "46.29 - 52.77",
        Decile_6: "52.78 - 59.25",
        Decile_7: "59.26 - 66.66",
        Decile_8: "66.67 - 75.58",
        Decile_9: "75.59 - 99.99",
        Decile_10: 100
    },
    {
        Measure_Name: "PACU Reintubation Rate",
        Measure_ID: "AQI 8",
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Outcome",
        Benchmark: "Y",
        Decile_3: "0.19 - 0.23",
        Decile_4: "0.24 - 0.28",
        Decile_5: "0.29 - 0.36",
        Decile_6: "0.37 - 0.50",
        Decile_7: "0.51 - 0.69",
        Decile_8: "0.70 - 1.18",
        Decile_9: "1.19 - 2.27",
        Decile_10: ">= 2.28"
    },
    {
        Measure_Name: "Pain Assessment and Follow-Up",
        Measure_ID: 131,
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "8.91 - 26.13",
        Decile_4: "26.14 - 50.11",
        Decile_5: "50.12 - 72.57",
        Decile_6: "72.58 - 91.42",
        Decile_7: "91.43 - 99.02",
        Decile_8: "99.03 - 99.99",
        Decile_9: "--",
        Decile_10: 100
    },
    {
        Measure_Name: "Perioperative Temperature Managament",
        Measure_ID: "AQI 13",
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Outcome",
        Benchmark: "Y",
        Decile_3: "73.28 - 90.78",
        Decile_4: "90.79 - 95.50",
        Decile_5: "95.51 - 99.16",
        Decile_6: "99.17 - 99.77",
        Decile_7: "99.78 - 99.99",
        Decile_8: "--",
        Decile_9: "--",
        Decile_10: 100
    },
    {
        Measure_Name: "Pneumococcal Vaccination in Elderly",
        Measure_ID: "PPRNET 19",
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "54.22 - 65.37",
        Decile_4: "65.38 - 69.78",
        Decile_5: "69.79 - 79.52",
        Decile_6: "79.53 - 82.50",
        Decile_7: "82.51 - 84.20",
        Decile_8: "84.21 - 86.05",
        Decile_9: "86.06 - 89.88",
        Decile_10: ">= 89.89"
    },
    {
        Measure_Name: "Pneumonia Vaccination Status for Older Adults",
        Measure_ID: 111,
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "12.24 - 24.02",
        Decile_4: "24.03 - 36.34",
        Decile_5: "36.35 - 48.51",
        Decile_6: "48.52 - 58.95",
        Decile_7: "58.96 - 68.05",
        Decile_8: "68.06 - 77.77",
        Decile_9: "77.78 - 90.19",
        Decile_10: ">= 90.20"
    },
    {
        Measure_Name: "Pneumonia Vaccination Status for Older Adults",
        Measure_ID: 111,
        Submission_Method: "EHR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "14.13 - 23.25",
        Decile_4: "23.26 - 33.02",
        Decile_5: "33.03 - 43.58",
        Decile_6: "43.59 - 53.96",
        Decile_7: "53.97 - 63.60",
        Decile_8: "63.61 - 74.54",
        Decile_9: "74.55 - 85.52",
        Decile_10: ">= 85.53"
    },
    {
        Measure_Name: "Pregnancy Test for Female Abdominal Pain Patients",
        Measure_ID: "ACEP 11",
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "44.35 - 52.67",
        Decile_4: "52.68 - 59.32",
        Decile_5: "59.33 - 67.29",
        Decile_6: "67.30 - 72.62",
        Decile_7: "72.63 - 84.72",
        Decile_8: "84.73 - 87.13",
        Decile_9: "87.14 - 89.23",
        Decile_10: ">= 89.24"
    },
    {
        Measure_Name: "Pregnancy Test for Female Abdominal Pain Patients",
        Measure_ID: "ECPR 26",
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "78.57 - 81.81",
        Decile_4: "81.82 - 84.61",
        Decile_5: "84.62 - 86.83",
        Decile_6: "86.84 - 88.93",
        Decile_7: "88.94 - 90.62",
        Decile_8: "90.63 - 92.69",
        Decile_9: "92.70 - 95.11",
        Decile_10: ">= 95.12"
    },
    {
        Measure_Name: "Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan",
        Measure_ID: 128,
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "39.80 - 45.63",
        Decile_4: "45.64 - 50.91",
        Decile_5: "50.92 - 56.68",
        Decile_6: "56.69 - 64.88",
        Decile_7: "64.89 - 75.81",
        Decile_8: "75.82 - 87.12",
        Decile_9: "87.13 - 97.33",
        Decile_10: ">= 97.34"
    },
    {
        Measure_Name: "Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan",
        Measure_ID: 128,
        Submission_Method: "EHR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "28.73 - 31.80",
        Decile_4: "31.81 - 34.45",
        Decile_5: "34.46 - 37.23",
        Decile_6: "37.24 - 40.19",
        Decile_7: "40.20 - 43.64",
        Decile_8: "43.65 - 48.75",
        Decile_9: "48.76 - 68.18",
        Decile_10: ">= 68.19"
    },
    {
        Measure_Name: "Preventive Care and Screening: Cholesterol - Fasting Low Density Lipoprotein (LDL-C) Test Performed",
        Measure_ID: "316A",
        Submission_Method: "EHR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "3.06 - 10.17",
        Decile_4: "10.18 - 23.74",
        Decile_5: "23.75 - 36.37",
        Decile_6: "36.38 - 47.57",
        Decile_7: "47.58 - 58.51",
        Decile_8: "58.52 - 67.18",
        Decile_9: "67.19 - 77.47",
        Decile_10: ">= 77.48"
    },
    {
        Measure_Name: "Preventive Care and Screening: Cholesterol - Fasting Low Density Lipoprotein (LDL-C) Test Performed: AND Risk-Stratified Fasting LDL-C",
        Measure_ID: "316B",
        Submission_Method: "EHR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "69.09 - 73.59",
        Decile_4: "73.60 - 76.39",
        Decile_5: "76.40 - 79.05",
        Decile_6: "79.06 - 81.40",
        Decile_7: "81.41 - 84.05",
        Decile_8: "84.06 - 87.49",
        Decile_9: "87.50 - 92.42",
        Decile_10: ">= 92.43"
    },
    {
        Measure_Name: "Preventive Care and Screening: Influenza Immunization",
        Measure_ID: 110,
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "11.57 - 21.39",
        Decile_4: "21.40 - 31.39",
        Decile_5: "31.40 - 41.31",
        Decile_6: "41.32 - 51.13",
        Decile_7: "51.14 - 62.04",
        Decile_8: "62.05 - 74.27",
        Decile_9: "74.28 - 91.83",
        Decile_10: ">= 91.84"
    },
    {
        Measure_Name: "Preventive Care and Screening: Influenza Immunization",
        Measure_ID: 110,
        Submission_Method: "EHR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "11.22 - 18.57",
        Decile_4: "18.58 - 24.99",
        Decile_5: "25.00 - 31.84",
        Decile_6: "31.85 - 38.92",
        Decile_7: "38.93 - 47.86",
        Decile_8: "47.87 - 59.99",
        Decile_9: "60.00 - 79.01",
        Decile_10: ">= 79.02"
    },
    {
        Measure_Name: "Preventive Care and Screening: Screening for Clinical Depression and Follow-Up Plan",
        Measure_ID: 134,
        Submission_Method: "EHR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "1.22 - 2.93",
        Decile_4: "2.94 - 5.93",
        Decile_5: "5.94 - 11.09",
        Decile_6: "11.10 - 17.87",
        Decile_7: "17.88 - 30.29",
        Decile_8: "30.30 - 51.32",
        Decile_9: "51.33 - 72.63",
        Decile_10: ">= 72.64"
    },
    {
        Measure_Name: "Preventive Care and Screening: Screening for Clinical Depression and Follow-Up Plan",
        Measure_ID: 134,
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "2.01 - 5.26",
        Decile_4: "5.27 - 14.88",
        Decile_5: "14.89 - 32.90",
        Decile_6: "32.91 - 50.42",
        Decile_7: "50.43 - 64.99",
        Decile_8: "65.00 - 85.25",
        Decile_9: "85.26 - 99.99",
        Decile_10: 100
    },
    {
        Measure_Name: "Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented",
        Measure_ID: 317,
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "24.74 - 35.47",
        Decile_4: "35.48 - 47.87",
        Decile_5: "47.88 - 62.14",
        Decile_6: "62.15 - 71.64",
        Decile_7: "71.65 - 79.36",
        Decile_8: "79.37 - 88.85",
        Decile_9: "88.86 - 98.87",
        Decile_10: ">= 98.88"
    },
    {
        Measure_Name: "Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented",
        Measure_ID: 317,
        Submission_Method: "EHR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "17.90 - 22.55",
        Decile_4: "22.56 - 25.80",
        Decile_5: "25.81 - 28.83",
        Decile_6: "28.84 - 31.69",
        Decile_7: "31.70 - 34.67",
        Decile_8: "34.68 - 38.96",
        Decile_9: "38.97 - 46.26",
        Decile_10: ">= 46.27"
    },
    {
        Measure_Name: "Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention",
        Measure_ID: 226,
        Submission_Method: "EHR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "72.59 - 81.59",
        Decile_4: "81.60 - 86.68",
        Decile_5: "86.69 - 90.15",
        Decile_6: "90.16 - 92.64",
        Decile_7: "92.65 - 94.67",
        Decile_8: "94.68 - 96.58",
        Decile_9: "96.59 - 98.51",
        Decile_10: ">= 98.52"
    },
    {
        Measure_Name: "Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention",
        Measure_ID: 226,
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "76.67 - 85.53",
        Decile_4: "85.54 - 89.87",
        Decile_5: "89.88 - 92.85",
        Decile_6: "92.86 - 95.14",
        Decile_7: "95.15 - 97.21",
        Decile_8: "97.22 - 99.10",
        Decile_9: "99.11 - 99.99",
        Decile_10: 100
    },
    {
        Measure_Name: "Preventive Care and Screening: Unhealthy Alcohol Use - Screening",
        Measure_ID: 173,
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "48.93 - 62.39",
        Decile_4: "62.40 - 71.86",
        Decile_5: "71.87 - 80.71",
        Decile_6: "80.72 - 88.21",
        Decile_7: "88.22 - 94.43",
        Decile_8: "94.44 - 98.48",
        Decile_9: "98.49 - 99.99",
        Decile_10: 100
    },
    {
        Measure_Name: "Primary Caries Prevention Intervention as Offered by Primary Care Providers, including Dentists",
        Measure_ID: 379,
        Submission_Method: "EHR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "0.79 - 0.96",
        Decile_4: "0.97 - 1.62",
        Decile_5: "1.63 - 2.03",
        Decile_6: "2.04 - 4.26",
        Decile_7: "4.27 - 6.59",
        Decile_8: "6.60 - 7.88",
        Decile_9: "7.89 - 14.28",
        Decile_10: ">= 14.29"
    },
    {
        Measure_Name: "Primary Open-Angle Glaucoma (POAG): Optic Nerve Evaluation",
        Measure_ID: 12,
        Submission_Method: "EHR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "73.33 - 82.41",
        Decile_4: "82.42 - 87.39",
        Decile_5: "87.40 - 90.90",
        Decile_6: "90.91 - 94.16",
        Decile_7: "94.17 - 96.57",
        Decile_8: "96.58 - 98.25",
        Decile_9: "98.26 - 99.57",
        Decile_10: ">= 99.58"
    },
    {
        Measure_Name: "Prostate Biopsy: Proportion of patients undergoing a prostate biopsy with a PSA < 4",
        Measure_ID: "MUSIC 8",
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "23.08 - 18.47",
        Decile_4: "18.46 - 16.01",
        Decile_5: "16.00 - 14.86",
        Decile_6: "14.85 - 13.65",
        Decile_7: "13.64 - 11.12",
        Decile_8: "11.11 - 10.35",
        Decile_9: "10.34 - 8.87",
        Decile_10: "<= 8.86"
    },
    {
        Measure_Name: "Prostate Biopsy: Proportion of patients undergoing initial prostate biopsy in the registry found to have prostate cancer",
        Measure_ID: "MUSIC 7",
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Outcome",
        Benchmark: "Y",
        Decile_3: "50.00 - 51.94",
        Decile_4: "51.95 - 53.02",
        Decile_5: "53.03 - 55.71",
        Decile_6: "55.72 - 57.13",
        Decile_7: "57.14 - 58.61",
        Decile_8: "58.62 - 59.51",
        Decile_9: "59.52 - 61.75",
        Decile_10: ">= 61.76"
    },
    {
        Measure_Name: "Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients",
        Measure_ID: 102,
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "42.12 - 54.99",
        Decile_4: "55.00 - 71.72",
        Decile_5: "71.73 - 82.13",
        Decile_6: "82.14 - 99.46",
        Decile_7: "99.47 - 99.99",
        Decile_8: "--",
        Decile_9: "--",
        Decile_10: 100
    },
    {
        Measure_Name: "Radiology: Exposure Time Reported for Procedures Using Fluoroscopy",
        Measure_ID: 145,
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "67.86 - 77.99",
        Decile_4: "78.00 - 84.61",
        Decile_5: "84.62 - 89.77",
        Decile_6: "89.78 - 93.41",
        Decile_7: "93.42 - 96.66",
        Decile_8: "96.67 - 99.59",
        Decile_9: "99.60 - 99.99",
        Decile_10: 100
    },
    {
        Measure_Name: "Rate of Postoperative Stroke or Death in Asymptomatic Patients Undergoing Carotid Artery Stenting (CAS)",
        Measure_ID: "AQI 21",
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Outcome",
        Benchmark: "Y",
        Decile_3: "38.75 - 44.99",
        Decile_4: "45.00 - 51.84",
        Decile_5: "51.85 - 57.13",
        Decile_6: "57.14 - 64.70",
        Decile_7: "64.71 - 77.49",
        Decile_8: "77.50 - 83.86",
        Decile_9: "83.87 - 95.82",
        Decile_10: ">= 95.83"
    },
    {
        Measure_Name: "Repeat screening colonoscopy recommended within one year due to inadequate bowel preparation",
        Measure_ID: "GIQIC 14",
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Outcome",
        Benchmark: "Y",
        Decile_3: "17.47 - 21.14",
        Decile_4: "21.15 - 26.76",
        Decile_5: "26.77 - 39.57",
        Decile_6: "39.58 - 53.00",
        Decile_7: "53.01 - 69.22",
        Decile_8: "69.23 - 75.42",
        Decile_9: "75.43 - 82.75",
        Decile_10: ">= 82.76"
    },
    {
        Measure_Name: "Rh Status Evaluation of Pregnant Women at Risk of Fetal Blood Exposure",
        Measure_ID: "ECPR 27",
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "67.05 - 72.78",
        Decile_4: "72.79 - 76.25",
        Decile_5: "76.26 - 79.30",
        Decile_6: "79.31 - 81.81",
        Decile_7: "81.82 - 85.95",
        Decile_8: "85.96 - 90.39",
        Decile_9: "90.40 - 94.14",
        Decile_10: ">= 94.15"
    },
    {
        Measure_Name: "Rheumatoid Arthritis (RA): Functional Status Assessment",
        Measure_ID: 178,
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "27.99 - 45.95",
        Decile_4: "45.96 - 64.17",
        Decile_5: "64.18 - 74.46",
        Decile_6: "74.47 - 81.36",
        Decile_7: "81.37 - 87.82",
        Decile_8: "87.83 - 92.34",
        Decile_9: "92.35 - 99.71",
        Decile_10: ">= 99.72"
    },
    {
        Measure_Name: "Risk standardized rate of patients who experienced a postoperative complication within 30 days following a Laparoscopic Roux-en-Y Gastric Bypass or Laparoscopic Sleeve Gastrectomy operation, performed as a primary (not revisional) procedure.",
        Measure_ID: "MBSAQIP 1",
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Outcome",
        Benchmark: "Y",
        Decile_3: "7.87 - 6.92",
        Decile_4: "6.91 - 5.74",
        Decile_5: "5.73 - 4.64",
        Decile_6: "4.63 - 3.86",
        Decile_7: "3.85 - 2.95",
        Decile_8: "2.94 - 1.00",
        Decile_9: "0.99 - 0.01",
        Decile_10: 0
    },
    {
        Measure_Name: "Screening Colonoscopy Adenoma Detection Rate",
        Measure_ID: 343,
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Outcome",
        Benchmark: "Y",
        Decile_3: "29.63 - 38.09",
        Decile_4: "38.10 - 41.85",
        Decile_5: "41.86 - 45.70",
        Decile_6: "45.71 - 48.69",
        Decile_7: "48.70 - 56.51",
        Decile_8: "56.52 - 63.40",
        Decile_9: "63.41 - 80.32",
        Decile_10: ">= 80.33"
    },
    {
        Measure_Name: "Screening for Abdominal Aortic Aneurysm",
        Measure_ID: "PPRNET 12",
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "2.78 - 4.19",
        Decile_4: "4.20 - 6.66",
        Decile_5: "6.67 - 7.83",
        Decile_6: "7.84 - 8.69",
        Decile_7: "8.70 - 15.93",
        Decile_8: "15.94 - 24.99",
        Decile_9: "25.00 - 46.42",
        Decile_10: ">= 46.43"
    },
    {
        Measure_Name: "Screening for Lipid Disorders in Adults",
        Measure_ID: "PPRNET 7",
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "83.62 - 87.97",
        Decile_4: "87.98 - 90.09",
        Decile_5: "90.10 - 90.94",
        Decile_6: "90.95 - 92.56",
        Decile_7: "92.57 - 93.62",
        Decile_8: "93.63 - 94.79",
        Decile_9: "94.80 - 96.40",
        Decile_10: ">= 96.41"
    },
    {
        Measure_Name: "Screening Mammography Abnormal Interpretation Rate (Recall Rate)",
        Measure_ID: "ACRad 5",
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Outcome",
        Benchmark: "Y",
        Decile_3: "13.98 - 11.03",
        Decile_4: "11.02 - 9.94",
        Decile_5: "9.93 - 9.24",
        Decile_6: "9.23 - 8.21",
        Decile_7: "8.20 - 7.22",
        Decile_8: "7.21 - 6.39",
        Decile_9: "6.38 - 5.27",
        Decile_10: "<= 5.26"
    },
    {
        Measure_Name: "Screening Mammography Cancer Detection Rate (CDR)",
        Measure_ID: "ACRad 3",
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Outcome",
        Benchmark: "Y",
        Decile_3: "3.54 - 4.32",
        Decile_4: "4.33 - 4.80",
        Decile_5: "4.81 - 5.15",
        Decile_6: "5.16 - 5.47",
        Decile_7: "5.48 - 5.71",
        Decile_8: "5.72 - 6.68",
        Decile_9: "6.69 - 8.10",
        Decile_10: ">= 8.11"
    },
    {
        Measure_Name: "Screening Mammography Invasive Cancer Detection Rate (ICDR)",
        Measure_ID: "ACRad 4",
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Outcome",
        Benchmark: "Y",
        Decile_3: "2.59 - 2.82",
        Decile_4: "2.83 - 3.51",
        Decile_5: "3.52 - 4.27",
        Decile_6: "4.28 - 4.63",
        Decile_7: "4.64 - 5.17",
        Decile_8: "5.18 - 5.56",
        Decile_9: "5.57 - 6.17",
        Decile_10: ">= 6.18"
    },
    {
        Measure_Name: "Screening Mammography Positive Predictive Value 2 (PPV2 - BiopsyRecommended)",
        Measure_ID: "ACRad 6",
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Outcome",
        Benchmark: "Y",
        Decile_3: "13.53 - 17.90",
        Decile_4: "17.91 - 20.33",
        Decile_5: "20.34 - 21.54",
        Decile_6: "21.55 - 24.99",
        Decile_7: "25.00 - 28.25",
        Decile_8: "28.26 - 39.46",
        Decile_9: "39.47 - 42.58",
        Decile_10: ">= 42.59"
    },
    {
        Measure_Name: "Screening or Therapy for Osteoporosis for Women Aged 65 Years and Older",
        Measure_ID: 39,
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "13.39 - 16.66",
        Decile_4: "16.67 - 20.39",
        Decile_5: "20.40 - 25.31",
        Decile_6: "25.32 - 33.99",
        Decile_7: "34.00 - 47.94",
        Decile_8: "47.95 - 64.65",
        Decile_9: "64.66 - 82.53",
        Decile_10: ">= 82.54"
    },
    {
        Measure_Name: "Serum Urate Monitoring",
        Measure_ID: "ACR 6",
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "26.67 - 36.35",
        Decile_4: "36.36 - 41.66",
        Decile_5: "41.67 - 44.29",
        Decile_6: "44.30 - 54.16",
        Decile_7: "54.17 - 60.86",
        Decile_8: "60.87 - 65.21",
        Decile_9: "65.22 - 73.90",
        Decile_10: ">= 73.91"
    },
    {
        Measure_Name: "Smoking Abstinence Measure",
        Measure_ID: "AQI 16",
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Outcome",
        Benchmark: "Y",
        Decile_3: "76.56 - 88.93",
        Decile_4: "88.94 - 97.51",
        Decile_5: "97.52 - 98.83",
        Decile_6: "98.84 - 99.38",
        Decile_7: "99.39 - 99.87",
        Decile_8: "99.88 - 99.99",
        Decile_9: "--",
        Decile_10: 100
    },
    {
        Measure_Name: "Stroke and Stroke Rehabilitation: Anticoagulant Therapy Prescribed for Atrial Fibrillation (AF) at Discharge",
        Measure_ID: 33,
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "29.55 - 43.18",
        Decile_4: "43.19 - 55.77",
        Decile_5: "55.78 - 73.75",
        Decile_6: "73.76 - 87.79",
        Decile_7: "87.80 - 95.22",
        Decile_8: "95.23 - 99.99",
        Decile_9: "--",
        Decile_10: 100
    },
    {
        Measure_Name: "Stroke and Stroke Rehabilitation: Discharged on Antithrombotic Therapy",
        Measure_ID: 32,
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "27.17 - 46.29",
        Decile_4: "46.30 - 67.85",
        Decile_5: "67.86 - 80.85",
        Decile_6: "80.86 - 90.90",
        Decile_7: "90.91 - 96.42",
        Decile_8: "96.43 - 99.99",
        Decile_9: "--",
        Decile_10: 100
    },
    {
        Measure_Name: "Stroke and Stroke Rehabilitation: Thrombolytic Therapy",
        Measure_ID: 187,
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Outcome",
        Benchmark: "Y",
        Decile_3: "14.55 - 34.99",
        Decile_4: "35.00 - 43.74",
        Decile_5: "43.75 - 52.37",
        Decile_6: "52.38 - 66.66",
        Decile_7: "66.67 - 76.24",
        Decile_8: "76.25 - 96.66",
        Decile_9: "96.67 - 99.99",
        Decile_10: 100
    },
    {
        Measure_Name: "Three Day All Cause Return ED Visit Rate - Adults",
        Measure_ID: "ECPR 12",
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Outcome",
        Benchmark: "Y",
        Decile_3: "6.96 - 6.54",
        Decile_4: "6.53 - 6.15",
        Decile_5: "6.14 - 5.79",
        Decile_6: "5.78 - 5.45",
        Decile_7: "5.44 - 5.13",
        Decile_8: "5.12 - 4.75",
        Decile_9: "4.74 - 4.30",
        Decile_10: "<= 4.29"
    },
    {
        Measure_Name: "Three Day All Cause Return ED Visit Rate - All Patients",
        Measure_ID: "ECPR 11",
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Outcome",
        Benchmark: "Y",
        Decile_3: "6.46 - 6.05",
        Decile_4: "6.04 - 5.72",
        Decile_5: "5.71 - 5.40",
        Decile_6: "5.39 - 5.08",
        Decile_7: "5.07 - 4.76",
        Decile_8: "4.75 - 4.35",
        Decile_9: "4.34 - 3.94",
        Decile_10: "<= 3.93"
    },
    {
        Measure_Name: "Three Day All Cause Return ED Visit Rate - Pediatrics",
        Measure_ID: "ECPR 13",
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Outcome",
        Benchmark: "Y",
        Decile_3: "4.29 - 3.90",
        Decile_4: "3.89 - 3.54",
        Decile_5: "3.53 - 3.19",
        Decile_6: "3.18 - 2.77",
        Decile_7: "2.76 - 2.34",
        Decile_8: "2.33 - 1.94",
        Decile_9: "1.93 - 1.36",
        Decile_10: "<= 1.35"
    },
    {
        Measure_Name: "Three Day All Cause Return ED Visit Rate with Placement Into Inpatient or Observation Status on Re-Visit",
        Measure_ID: "ECPR 17",
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Outcome",
        Benchmark: "Y",
        Decile_3: "1.46 - 1.29",
        Decile_4: "1.28 - 1.16",
        Decile_5: "1.15 - 1.06",
        Decile_6: "1.05 - 0.96",
        Decile_7: "0.95 - 0.84",
        Decile_8: "0.83 - 0.71",
        Decile_9: "0.70 - 0.55",
        Decile_10: "<= 0.54"
    },
    {
        Measure_Name: "Three day return rate ED",
        Measure_ID: "ACEP 12",
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Outcome",
        Benchmark: "Y",
        Decile_3: "15.53 - 14.41",
        Decile_4: "14.40 - 13.46",
        Decile_5: "13.45 - 12.01",
        Decile_6: "12.00 - 11.11",
        Decile_7: "11.10 - 10.52",
        Decile_8: "10.51 - 10.11",
        Decile_9: "10.10 - 9.22",
        Decile_10: "<= 9.21"
    },
    {
        Measure_Name: "Tobacco Use and Help with Quitting Among Adolescents",
        Measure_ID: 402,
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "74.10 - 81.15",
        Decile_4: "81.16 - 87.49",
        Decile_5: "87.50 - 90.37",
        Decile_6: "90.38 - 92.72",
        Decile_7: "92.73 - 95.15",
        Decile_8: "95.16 - 97.50",
        Decile_9: "97.51 - 99.99",
        Decile_10: 100
    },
    {
        Measure_Name: "Tobacco Use: Screening and Cessation Intervention",
        Measure_ID: "PPRNET 23",
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "83.22 - 86.67",
        Decile_4: "86.68 - 92.28",
        Decile_5: "92.29 - 92.58",
        Decile_6: "92.59 - 92.79",
        Decile_7: "92.80 - 94.29",
        Decile_8: "94.30 - 96.92",
        Decile_9: "96.93 - 98.34",
        Decile_10: ">= 98.35"
    },
    {
        Measure_Name: "Train of Four Monitor Documented After Last Dose of Non-depolarizing Neuromuscular Blocker",
        Measure_ID: "ASPIRE 2",
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "78.96 - 80.94",
        Decile_4: "80.95 - 82.72",
        Decile_5: "82.73 - 83.47",
        Decile_6: "83.48 - 84.42",
        Decile_7: "84.43 - 86.07",
        Decile_8: "86.08 - 88.08",
        Decile_9: "88.09 - 90.33",
        Decile_10: ">= 90.34"
    },
    {
        Measure_Name: "Tuberculosis Prevention for Psoriasis and Psoriatic Arthritis Patients on a Biological Immune Response Modifier",
        Measure_ID: 337,
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "6.82 - 16.12",
        Decile_4: "16.13 - 24.13",
        Decile_5: "24.14 - 47.59",
        Decile_6: "47.60 - 90.90",
        Decile_7: "90.91 - 99.99",
        Decile_8: "--",
        Decile_9: "--",
        Decile_10: 100
    },
    {
        Measure_Name: "Tuberculosis Test Prior to First Course Biologic Therapy",
        Measure_ID: "ACR 4",
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "23.08 - 37.92",
        Decile_4: "37.93 - 47.16",
        Decile_5: "47.17 - 55.04",
        Decile_6: "55.05 - 64.28",
        Decile_7: "64.29 - 72.33",
        Decile_8: "72.34 - 84.61",
        Decile_9: "84.62 - 94.96",
        Decile_10: ">= 94.97"
    },
    {
        Measure_Name: "Ultrasound guidance for central line placement",
        Measure_ID: "THPSO 5",
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "7.83 - 9.08",
        Decile_4: "9.09 - 15.28",
        Decile_5: "15.29 - 23.15",
        Decile_6: "23.16 - 33.32",
        Decile_7: "33.33 - 48.27",
        Decile_8: "48.28 - 56.75",
        Decile_9: "56.76 - 83.94",
        Decile_10: ">= 83.95"
    },
    {
        Measure_Name: "Urinary Incontinence: Assessment of Presence or Absence of Urinary Incontinence in Women Aged 65 Years and Older",
        Measure_ID: 48,
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "16.31 - 29.03",
        Decile_4: "29.04 - 42.90",
        Decile_5: "42.91 - 57.07",
        Decile_6: "57.08 - 76.52",
        Decile_7: "76.53 - 89.12",
        Decile_8: "89.13 - 96.91",
        Decile_9: "96.92 - 99.99",
        Decile_10: 100
    },
    {
        Measure_Name: "Use of Appropriate Medications for Asthma",
        Measure_ID: 311,
        Submission_Method: "EHR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "16.67 - 41.02",
        Decile_4: "41.03 - 58.05",
        Decile_5: "58.06 - 69.05",
        Decile_6: "69.06 - 75.48",
        Decile_7: "75.49 - 81.81",
        Decile_8: "81.82 - 87.49",
        Decile_9: "87.50 - 92.97",
        Decile_10: ">= 92.98"
    },
    {
        Measure_Name: "Use of High-Risk Medications in the Elderly",
        Measure_ID: 238,
        Submission_Method: "EHR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "26.32 - 21.23",
        Decile_4: "21.22 - 15.75",
        Decile_5: "15.74 - 9.40",
        Decile_6: "9.39 - 3.86",
        Decile_7: "3.85 - 0.91",
        Decile_8: "0.90 - 0.01",
        Decile_9: "--",
        Decile_10: 0
    },
    {
        Measure_Name: "Use of High-Risk Medications in the Elderly",
        Measure_ID: 238,
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "20.00 - 15.02",
        Decile_4: "15.01 - 10.54",
        Decile_5: "10.53 - 6.23",
        Decile_6: "6.22 - 2.64",
        Decile_7: "2.63 - 1.00",
        Decile_8: "0.99 - 0.29",
        Decile_9: "0.28 - 0.01",
        Decile_10: 0
    },
    {
        Measure_Name: "Use of High-Risk Medications in the Elderly",
        Measure_ID: "PPRNET 26",
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "83.00 - 86.17",
        Decile_4: "86.18 - 87.45",
        Decile_5: "87.46 - 88.88",
        Decile_6: "88.89 - 89.62",
        Decile_7: "89.63 - 90.72",
        Decile_8: "90.73 - 92.85",
        Decile_9: "92.86 - 94.16",
        Decile_10: ">= 94.17"
    },
    {
        Measure_Name: "Vascular Assessment of patients with chronic leg ulcers",
        Measure_ID: "CDR 10",
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "28.14 - 36.46",
        Decile_4: "36.47 - 43.95",
        Decile_5: "43.96 - 57.95",
        Decile_6: "57.96 - 68.13",
        Decile_7: "68.14 - 73.73",
        Decile_8: "73.74 - 77.31",
        Decile_9: "77.32 - 79.51",
        Decile_10: ">= 79.52"
    },
    {
        Measure_Name: "Weight Assessment and Counseling for Nutrition and Physical Activity for Children and Adolescents",
        Measure_ID: 239,
        Submission_Method: "EHR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "25.72 - 28.72",
        Decile_4: "28.73 - 30.38",
        Decile_5: "30.39 - 31.52",
        Decile_6: "31.53 - 32.30",
        Decile_7: "32.31 - 32.80",
        Decile_8: "32.81 - 33.32",
        Decile_9: "33.33 - 34.94",
        Decile_10: ">= 34.95"
    },
    {
        Measure_Name: "Wound Bed Preparation Through Debridement of Necrotic or Non-viable Tissue",
        Measure_ID: "CDR 11",
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "56.64 - 65.37",
        Decile_4: "65.38 - 78.33",
        Decile_5: "78.34 - 86.19",
        Decile_6: "86.20 - 94.63",
        Decile_7: "94.64 - 97.10",
        Decile_8: "97.11 - 98.37",
        Decile_9: "98.38 - 99.34",
        Decile_10: ">= 99.35"
    },
    {
        Measure_Name: "Zoster (Shingles) Vaccination",
        Measure_ID: "PPRNET 20",
        Submission_Method: "Registry/QCDR",
        Measure_Type: "Process",
        Benchmark: "Y",
        Decile_3: "11.15 - 32.73",
        Decile_4: "32.74 - 41.89",
        Decile_5: "41.90 - 53.56",
        Decile_6: "53.57 - 56.51",
        Decile_7: "56.52 - 58.25",
        Decile_8: "58.26 - 66.42",
        Decile_9: "66.43 - 68.85",
        Decile_10: ">= 68.86"
    }
];
$("#result").html(specializations[0].specialization);

Comments